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ABSTRACT
The role of stress has long been recognized in schizophrenia; several theories have
identified the role of stress as an important factor in the etiology of schizophrenia. A handful of
studies have used laboratory psychosocial stressors to examine cortisol stress response in
schizophrenia; the results obtained have consistently suggested that the stress response is
attenuated in people with schizophrenia. Present study set out to examine stress responsivity in
schizophrenia relative to healthy controls. A laboratory stress test was used to investigate cortisol
response, heart rate and task appraisal in a sample of 17 healthy controls and 16 men diagnosed
with schizophrenia who were clinically stable at the time of testing.
No group differences were found in task appraisal of the TSST or heart rate.
Nevertheless, similar to previous research, an attenuated cortisol response was observed in the
schizophrenia group, implicating potential disruption of the HPA axis in schizophrenia.
Associations between cortisol response and performance on measures of social cognition
and everyday functioning skills were also examined. Lastly, the relationship between childhood
trauma and cortisol stress response was examined.
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CHAPTER 1
INTRODUCTION
Schizophrenia is a neurodevelopmental disorder characterized by psychosis, negative
symptoms, and impairments in cognitive functioning and social cognition. Psychotic disorders
are arguably the most devastating of the psychiatric illnesses, resulting in long-term disability,
and high costs incurred both by the individual and society (Foster & Goa, 1999). The impact of
stress on individuals with schizophrenia is monumental. The diastasis-stress model proposes that
schizophrenia emerges in the context of a biological predisposition to develop the disorder and
environmental stress. The hypothalamic-pituitary-adrenal (HPA) axis has been identified as an
endocrine structure that triggers physiological responses to a subjective experience and is
commonly investigated via cortisol secretion (e.g., Walker & Diforio, 1997; Nuechterlein &
Dawson, 1982).
Stress has been implicated as both a contributing factor in the onset of psychosis and as a
factor in the exacerbation of its course. A meta-analysis of 41 studies which included 79,000
individuals concluded that people with childhood trauma were nearly three times (odds ratio =
2.75-2.99) more likely to exhibit psychotic symptoms than those who did not experience
childhood trauma (Varese et al., 2012). Additionally, stress has been implicated in exacerbating
the course of psychotic illness. Social stressors exacerbate psychotic symptoms and are
associated with higher relapse rates and more hospitalizations (Remington et al., 2013; Doering
et al., 1998) and symptomatic relapse is associated with worse psychosocial functioning
(Stefanopoulou et al., 2011).
While the body of literature examining HPA axis response to laboratory-based
psychosocial stressors in schizophrenia is fairly small, the findings have been largely consistent.
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Patients with chronic schizophrenia generally match or exceed healthy controls on measures of
autonomic arousal (e.g., heart rate, blood pressure) and subjective self-report of stress during the
laboratory psychosocial stressors; however, patients had attenuated cortisol levels in response to
laboratory induced psychosocial stress (Brenner et al., 2009; Jansen et al., 2000; Jansen et al.,
1998). Similar findings have been reported in first episode patients (van Venrooij et al., 2012)
and those at ultra-high risk (UHR) for developing schizophrenia (Pruessner et al., 2013),
suggesting that attenuated cortisol response is not the direct result of exposure to psychotropic
medications, disease chronicity or other associated factors, such as institutionalization, decrease
opportunity for appropriate social interactions, among others. Interestingly, cortisol responses to
physiological stressors such physical exercise (Jansen et al., 2000) and metabolic stressors have
been similar in patients and healthy controls, suggesting a potentially unique HPA axis response
to social stressors in schizophrenia (Jansen et al., 2000; Jansen et al., 1998).
Despite the consistency of these findings, their interpretation remains unclear. In order to
clarify and extend prior findings, the present study’s goals were to further examine the
aforementioned attenuation in cortisol response in relationship to 1) objective measures of social
functioning, 2) history of childhood adversity, and 3) subjective experience of stress. The study
will also address potential methodological confounds that may have caused inconsistencies in the
results of prior studies. Each of these goals are explained below.
The first aim, or to examine the relationship between cortisol response and measures of
social functioning, is intended to provide additional information for how judgment and
subjective experience impact hormonal responding in schizophrenia. Some aspects of
psychosocial functioning have been examined among people with schizophrenia who have
undergone laboratory psychosocial stressors. For example, people with schizophrenia report
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greater use of passive or avoidant coping strategies in general (Jansen et al., 2000; Jansen et al.,
1998) and when asked to evaluate hypothetical social scenarios (Jansen et al., 1998). Patients
reported greater use of confrontive and avoidant coping strategies during the psychosocial
laboratory stressor (Jansen et al., 2000).
The present study intends to extend this goal by examining the relationship between
social cognition, task appraisal, and physiological stress response. Impairment in social cognitive
functioning is well established in schizophrenia (e.g., Pinkham et al., 2014). Additionally, there
is strong evidence for defeatist performance beliefs and poor self-efficacy in schizophrenia.
Because task appraisal has direct effects on the stress response, the current study will examine
how objective measures of social cognition and defeatist performance beliefs can be used to
understand the cortisol stress response in schizophrenia.
The second aim, to examine the relationship between childhood adversity and cortisol
response to laboratory stressors, has not been directly investigated in the existing literature and
may assist with differentiating whether abnormal cortisol response could be better understood as
the result of early environmental stressors or as a direct expression of schizophrenia pathology.
Exposure to early adversity has deleterious effects on the neurobiological mechanisms that
underlie HPA axis mediated stress responsivity. Blunted cortisol response has been documented
among healthy controls with a history of child abuse free of clinical diagnoses (e.g., Carpenter et
al., 2007). This finding was interpreted as the result of desensitization of the HPA axis following
long-term activation due to chronic stress. Given the high prevalence of childhood adversity in
schizophrenia it is not clear whether the observed attenuation is due to schizophrenia specific
pathology, a result of childhood trauma, or an interaction of the two.
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Lastly, the present study aims to replicate past research using a live evaluative panel
instead of an imagined one. The studies conducted with schizophrenia did not use live
confederates in the room, but have obtained the observed results by either leading the
participants to believe that they are being currently observed and evaluated during a performance
task. While an imagined panel has been demonstrated to increase autonomic response to some
degree, at least one study has demonstrated that the cortisol responses obtained in healthy
controls with imagined judges were significantly lower than those obtained from subjects who
were asked to speak in front of a live audience (Kelly et al., 2007).
The present study will focus on the stress response of men only to preserve the
heterogeneity of the study sample, as research has indicated that males and females have
characteristically dissimilar responses (Kudielka, B.M., Hellhammer, D.H., & Wüst, S, 2009)
and have shown differential associations with variables of interest (e.g., Smeets et al., 2009).
A potential limitation with the present body of research is the use of overly generalized
scales to examine distress. Difference between challenge and threat depends on whether an
individual appraises personal resources as adequate or not to meet a specific challenge
(Blascovich & Tomaka, 1996). Dickerson and Kemeny (2004) did not find a relationship
between subjective self-report of distress and cortisol response in response to laboratory
stressors. Similarly, two other meta-analyses did not find a relationship between subjective selfreport and immune system outcomes in everyday settings (Segerstrom & Miller, 2004; Herbert &
Cohen, 1993). Denson and colleagues (2009) have suggested that these findings were not
significant due to the use of overly generalized scales, or that classifying emotions into broad
dimensions (e.g., positive and negative) may obscure relationships between specific emotions
and the stress response. This meta-analysis replicated the lack of relationship between global
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mood states and cortisol responses, and used statistical models to demonstrate that types of
cognitive appraisals are significantly associated with cortisol responses.
Studies have indicated that subjective interpretation of day-to-day experience may differ
for people with schizophrenia: individuals diagnosed with schizophrenia are more likely to
perceive both positive and negative events as more stressful, less controllable, and handled less
skillfully than healthy controls (Horan et al., 2005). This is particularly relevant considering the
fact that studies in healthy controls have reported an association between anxiety and magnitude
of cortisol stress response using a more nuanced measure of threat and challenge (Gaab,
Rohleder, Nater, & Ehlert, et al., 2005). In summary, these studies suggest that understanding
stress responsivity in schizophrenia may have broad implications for symptom management.
Based on these considerations, the current study proposes to examine changes in cortisol
levels in schizophrenia in response to laboratory based stress, and associations with social
cognitive abilities and the presence of childhood trauma. In this context, social cognitive
abilities, and particularly social cognition, are thought to mediate stress response and cortisol
level fluctuations in schizophrenia such that those individuals with deficient social perception
will experience greater stress and larger fluctuations in cortisol levels. The presence or absence
of childhood trauma is expected to influence baselines levels of cortisol and be associated with
blunted response to laboratory stressors.
In the following sections, relevant literature regarding HPA axis, childhood trauma,
schizophrenia, social cognition, and findings from laboratory based stress procedures are
discussed to provide a basis for the study hypotheses.
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CHAPTER 2
REVIEW OF RELATED LITERATURE
Conceptualizing Stress
Early models conceptualized stress as an all-or-nothing mechanism: Selye (1973) stated,
“stress producing factors … are different, and yet they all produced essentially the same biologic
stress response” (p. 692). According to Weiner (1992), Selye was biased by the unavoidable or
overpowering stimuli used in his research, which override the nuanced differences in behavior or
physiological responses; additionally Selye overestimated the role of stress in causing the nonspecific (e.g., lethargy, loss of appetite) symptoms of illness in humans. Conceptualizations of
stress shifted in later years as scientists realized that organisms must have more finely tuned
response systems to survive, and that stressors, such as hunger, thirst, or social threat must elicit
different responses for an animal to be effective. Following WWII researchers started examining
stress from a psychosocial perspective. This perspective was warranted as one-third of the
American soldiers returning from the war did not sustain any physical injury, but suffered from
exposure to loud noise, extreme fear, exertion, or grief following deaths of colleagues (Weiner,
1992).
Based on their work with animals, Sawchenko, Li, & Ericsson (2000) argue for the
existence of a dichotomous responding system to interoceptive, responsive to internal
environments, and exteroceptive, responsive to external environments, stressors. The
introcepetive system, which is mediated by subcortical regions and is largely reflexive, does not
require conscious perception of the stressor in order for it to impact the HPA axis. This would
include such stressors as temperature, physical activity, or metabolic stressors. The exteroceptive
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system is activated by stressors that must be perceived and elicit cognitive or emotional
processing, as demonstrated by animal studies using restraint. In humans the exteroceptive
system is responsive to psychological and psychosocial stressors and can be examined via
laboratory psychosocial stressors where perceived control and social evaluation are associated
with the magnitude of the cortisol response (e.g., Schlotz, Hammerfald, Ehlert, & Gaab, 2011).
Even for stress responses that are mediated by the exteroperceptive system, animal models
indicate distinct behavioral responses for different classes of stress responses such as fighting,
fleeing, or submitting (Weiner, 1992). These considerations call for a more nuanced approach to
the study of the HPA axis and stress responses in humans.
The integrated specificity model posits that posits that distinct emotions are associated
with unique physiological responses (Dickerson, Gruenewald, & Kemeny 2004; Kemeny 2003;
Weiner, 1992). Figure 1 illustrates how appraisal can impact emotional and physiological
functioning (Diagram adapted from Kemeny, 2003).

Figure 1
Relationship between Cognitive Appraisal and Physiological Response
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Psychological stressors can be characterized as threats or challenges. If the demands of
the stressor are assessed to exceed the resources of the organism the stressor can be considered a
“threat;” however, if the organism appraises its resources as adequate the stressor can be
classified as a “challenge” (Blascovich & Tomaka, 1996). This requires the simultaneous
assessment of task demands (primary assessment) and one’s capabilities (secondary assessment).
Threat and challenge create distinct physiological responses in the individual perceiving the
situation: while both states are associated with autonomic activation, challenge is associated with
increased peripheral resistance, resulting in increased blood pressure (Kemny, 2003). Thus, these
findings further demonstrate that cognitive appraisal can have direct effects on physiological
responses. Weiner (1992) listed several determinants of the stress response: situational novelty
and unpredictability, previous experience, role of the participant, appraisal of performance, and
individual coping mechanisms.
HPA Axis Function
The human body works to preserve homeostasis in response to threats to well-being, or
stressors. Stressors can be chronic or short-term, and can include both psychological and
physical elements, such as perceived threat to the physical self or one’s social standing,
infection, starvation, and fatigue, to name a few. Several physiological mechanisms work
together to in response to stress.
The hypothalamic-pituitary-adrenal (HPA) axis initiates physiological responses to stress
by orchestrating a hormonal cascade that starts within minutes or hours after encountering a
stressor (Walker, Mittal, & Tessner, 2008; Sawchenko et al., 2000). Once a stressor is
recognized, the periventricular nucleus (PVN) of the hypothalamus releases corticotrophinreleasing hormone (CRH), which triggers the release of the adrenocorticotropic hormone
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(ACTH) from the pituitary gland, which in turn triggers release of glucocorticoids (GC),
including cortisol, from the adrenals.
Under normal conditions cortisol plays a major role in homeostasis; under stressful
conditions cortisol production increases and facilitates an adaptive physiological response.
Cortisol production is regulated by circadian rhythms: there is a sharp elevation in production
upon awakening, and steady decline throughout the day (Weitzman et al., 1971). Most human
cells have mineralocorticoid (MR) cortisol receptors, thereby allowing the hormone to regulate a
variety of bodily systems including metabolic, immune, and cardiovascular functioning
(Dedovic, Duchesne, Andrews, Engert, & Pruessner, 2009). Under normal conditions, cortisol is
secreted at a rate of 10 milligrams per day; in response to a stressor cortisol levels can increase
10-fold (Schimmer & Parker, 1996). Unless there are elevations in production, cortisol is mainly
involved in homeostatic functioning due to the high affinity of MR receptors. Increased
concentrations of cortisol allow for it to bind to lower affinity GC receptors and activate
mechanisms that promote short-term survival of the organism in response to stress by: 1)
increasing the supply of oxygen and glucose to the skeletal muscles, heart and brain to bolster
physiological functioning; 2) conserving energy by shutting down the reproductive, immune, and
digestive systems; 3) promoting analgesia; and 4) activating the peripheral autonomic nervous
system (Sapolsky 2000).
Prolonged cortisol elevation is believed to have detrimental effects on neurophysiology,
particularly the hippocampal functioning (King & Hegadoren, 2002) and is associated with lower
levels of brain derived neurotropic factor (BDNF; Hansen et al., 2006). The hippocampus is
particularly sensitive to GC-mediated neurotoxicity because it has the highest GC receptor
density of any brain region. Hippocampal damage in turn may exacerbate cortisol dysregulation
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because it provides negative feedback for corticosteroid production (Jankord & Herman, 2008).
While the exact nature of the resulting dysfunction is unclear, several mechanisms have been
proposed. McEwen (1998) proposed a glucocorticoid-cascade hypothesis suggesting that chronic
stress leads to hippocampal “wear and tear,” resulting in HPA axis dysregulation and cognitive
impairment. Repeated or chronic stress may lead to increased negative feedback through
sensitization to GC activity and result in up-regulation in the number of GC receptors thereby
increasing negative feedback and resulting in hypo-cortisolism (King & Hegadoren, 2002).
Others have suggested that chronic stress leads to hyper-cortisolism by increasing the central
tone of the HPA axis, down regulation to GC receptors in key feedback regions, and facilitation
of corticosteroid responses to stressors (Jankord & Herman, 2008).
The effects of psychosocial stressors are modulated by limbic circuits, which involve the
amygdala, hippocampus, and orbital/medial prefrontal cortex. The stressor is appraised by the
prefrontal cortex and anterior cingulate. Subcortical structures, including the hippocampus and
amygdala, also participate in stressor appraisal. Signal integration has been observed to occur at
the hypothalamic and brain stem structures.
Interpretation of findings is further complicated by the fact that cortisol production is
regulated through negative feedback at various levels of the HPA axis. Negative signaling occurs
at the hypothalamus and pituitary gland when increased levels of free cortisol are detected and
halts of the release of CRH and ACTH. The effects of these mechanisms are gradual: unbound
levels of cortisol continue to increase for 15 to 20 minutes following a stressor’s cessation
(Kirschbaum & Hellhammer, 2000).
Methods for studying the HPA axis
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Cortisol is the most frequently sampled hormone and can indicate dysfunction at several
levels of the HPA axis. Cortisol is often studied as a proxy measure of HPA axis functioning
because it is the final product of the HPA axis in humans, it plays a critical role in maintaining
homeostasis, and it is relatively easy to sample using minimally invasive procedures such as
saliva and urine sampling, and blood draws. Salivary sampling is relatively common as it is a
practical, reliable, non-stressful, and non-invasive approach. Additionally, because salivary
cortisol is 100% unbound, it reflects the substrates available for interaction with receptors and is
arguably the most relevant measure of bioactive cortisol (Hellhammer, Wüst, & Kudielka, 2009).
In addition to these methods, cortisol levels can also be examined in the cerebrospinal fluid
(CSF). Salivary, urinary, and plasma cortisol levels are highly correlated (Weinstein, Diforio,
Schiffman, Walker, & Bonsall, 1999).
Several techniques have been used to investigate cortisol levels. Some methods are more
passive where natural levels of cortisol are observed during resting condition, known as “basal
levels,” such as when a person is just waking up, or during the afternoon. Another approach has
been to examine response to stressors, or challenge studies, used to investigate HPA axis
response capacity. Researchers have also used physiological challenge studies, or activation of
the HPA axis under controlled conditions, such as pharmacological agents with known effects on
the HPA axis, as stressors to examine HPA axis functioning.
The best known among the pharmacological challenge tests is the dexamethasone
suppression test (DST). Some forms of HPA axis hyperactivity are thought to be due to reduced
sensitivity to dexamethasone, a glucocorticoid that provides negative feedback on the production
adrenocorticotropic hormone and cortisol. By binding to receptors distributed throughout the
HPA axis, glucocorticoids provide negative feedback, or suppression of synthesis and release of
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CRH in the PVN (Owens & Nemeroff, 1993). DST examines the effects of negative-feedback of
dexamethasone through anterior pituitary GR activation (Pariante & Miller, 2001). DST is
ingested before which is taken right before bed. Cortisol is sampled the following morning and
afternoon and compared to the samples obtained when no pharmaceutical agent was
administered. Reduced levels of cortisol the morning after ingestion are interpreted as evidence
of successful negative feedback of the HPA axis. Non-suppression following DST administration
is more common among patients with Cushing’s syndrome, and depression, to name a few
(Walker et al., 2008). Other sets of patients have shown a response known as hyper-suppression,
or depressed levels of cortisol following DST test. Hyper-suppression is more typically found
among individuals who have sustained a trauma, such as veterans, natural disaster victims, and
adults who have histories of sexual abuse (Fries, Hesse, Hellhammer, & Hellhammer, 2005;
Dickerson et al., 2004).
Other pharmacological challenges assess adrenal cortex functioning by administrating
synthetic ACTH. Smaller doses are used to assess receptor sensitivity, while larger doses can be
used to examine maximum adrenal capacity. Physiological and environmental stressors can also
be used to examine cortisol responding. Stressors such as physical exercise, keeping one’s hand
in cold water, or uncontrollable background noise (e.g., Albus, Ackenheil, Engel, & Müller,
1982) can be used to elicit a cortisol responses. Response to physiological stressors does not
appear to be impacted by habituation as suggested by similar responses seen across multiple time
points (O’Connor & Corrigan, 1987). Laboratory based procedures to induce psychological
stress include mental calculation tasks and public speaking tasks. The most commonly used is
the Trier Social Stress Test (TSST; Kirschbaum, Pirke, & Hellhammer, 1993).
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The TSST is an acute, naturalistic stress protocol used in laboratories to induce social
stress. The task is unique because it does not rely on self-report, which is susceptible to reporting
and cognitive biases. Generally, the task requires the participant to compose and deliver a speech
in front of a panel. This allows sampling of several phases of the stress response including
baseline measures of stress hormones following a period of habituation, anticipation anxiety,
peak stress response, and resolution.
Converging lines of evidence indicate that the TSST is effective at eliciting a stress
response. TSST is subjectively stressful as indicated by participant self-report and physiological
indicators of stress including increased heart rate, increased stress hormones, and immune system
functioning (Dickerson & Kemeny, 2004). The TSST and modified versions of the laboratory
stressor, appear to have robust effects and have been used with several clinical and non-clinical
populations including patients with mood disorders (Houtepen et al., 2013; Steen et al., 2011),
post-traumatic stress disorder (Simeon, Knutelska, et al., 2007; Simeon, Yehuda, et al., 2007),
healthy controls with a history of childhood trauma (Carpenter et al., 2007; Elzinga et al., 2007),
schizophrenia (Jansen et al., 1998, 2000), anxiety disorders (Petrowski, Herold, Joraschky,
Wittchen, & Kirschbaum, 2010; van Veen et al., 2009), and first-degree relatives of people with
mood disorders (Houtepen et al., 2013; Ellenbogen et al., 2006), to name a few.
A meta-analysis of 208 studies of healthy controls on acute psychological laboratory
stress tasks analyzed these tasks to determine which components are more effective at eliciting a
stress response (Dickerson & Kemeny, 2004). The tasks reviewed fit broadly into the following
five categories: cognitive tasks; public speaking/verbal interaction; public speaking/cognitive
tasks; emotion induction; and noise exposure. Findings suggest that only the first three categories
were demonstrated to have significant impact on the stress response. Further analyses revealed
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that uncontrollability and social evaluation were each significant predictors of cortisol
production, presumably because these conditions create situations that threaten the participants’
social standing.
Effective components of the TSST have also been examined through systematic
modification of the task. Experimental variation of the TSST has suggested that the response
elicited by the social stressor is incremental, and affected by the participant’s subjective
experience, individual factors, and nature of the stressor. Gruenewald and colleagues (2004)
determined that social stress, and not the task of delivering a speech, is associated with the stress
response. There were significant differences in subjective and physiological responses of healthy
controls asked to deliver a speech in front of an audience compared to those of subjects asked to
deliver the same speech alone. Interestingly, while both groups reported comparable increases of
anxiety and performance esteem, the group exposed to an audience reported more shame and less
social self-worth. The group exposed to an audience had significant increases of salivary cortisol
following the task and within this group greater increases in shame and greater reductions of
social self-worth were associated with greater rises in cortisol. This suggests that different
emotions may cause increases in salivary cortisol.
Other researchers examined the effect of the physical presence of a judging panel, and the
interaction between the presence & absence of a judging panel and gender. Kelly and colleagues
(2007) found that exposure to a panel in the room, an imagined panel (behind a one way mirror),
and a virtual reality panel all caused rises in cortisol level in a mixed gender sample of healthy
controls. Although no differences in subjective appraisal of task difficulty were detected between
the conditions, peak cortisol levels for participants in front of a live panel were significantly
higher than the other conditions: the participants delivering the speech in front of a live panel
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exhibited cortisol elevations that were on average 90% higher than baseline, while those
delivering the speech to an imagined or virtual panel had increases of 30% and 20% from
baseline, respectively. No gender differences were detected. In contrast, a study of healthy,
young men did not find group differences in cortisol response between men assigned randomly
to one of four conditions: two judges in the room (n=20), two judges out of the room (n=20), a
judge in the room (n=10), or a judge out of the room (n=10) (Andrews et al., 2007). All of the
subjects were told that their speech was being videotaped for future evaluation by an expert. The
discrepancy in the findings may be due to the fact that Kelly et al. (2007) had a larger sample of
participants (although the actual number of subjects per group was not reported, equal
distribution among the conditions would indicate that this study had roughly 62 subjects per
condition) or due to a greater number of panel members used (Kelly et al. (2007) had four).
Interestingly, Andrews et al. (2007) findings were not replicated in a similar study of healthy,
young women where subjects speaking in front of a live panel had a larger cortisol response than
women delivering a speech to an imagined panel (Wadiwalla, et al., 2010). These findings may
suggest that physical presence may differentially impact males and females. Notably, no
differences were found when comparing subjects speaking about oneself (high ego involvement)
vs. someone else (low ego involvement) (Wadiwalla, 2010).
While effective components of social stress tasks have been largely agreed upon, the
emotional predictors of the stress response are not as understood. Denson, Spanovic, and Miller
(2009) used high inference coding procedures in their meta-analytic review of laboratory
stressors, and have found that exemplars of cognitive appraisals, basic emotions, rumination and
worry, and social treat are significantly associated with physiological responses to laboratory
stressors. These authors argue that negative affect is too broad a dimension to capture the
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nuances of the physiological stress response, and attribute the field’s lack of success in finding
these predictors to use of broad global measures or behavioral categorizations (e.g., approach,
avoidance). Authors recommended use of more measures that capture specific emotional states
(e.g., anger, worry, relief).
Efforts have been made to understand the relationship between the stress response and
performance. In healthy controls lower cortisol response when faced with a stressor has been
associated with positive outcomes. Henry (1992) claimed that a lower adrenocortical response is
associated with successful coping, and higher response tends to be an indicator of hopelessness
or helplessness. Experimental evidence appears to support this finding as there was a significant
negative association between self-esteem and cortisol response in subjects assigned to complete a
difficult math test (Pruessner, Hellhammer, & Kirschbaum, 1999).
Gaab and colleagues (2005) found that anticipatory cognitive appraisal accounted for
35% of the variance in salivary cortisol response to a social stressor in a sample of male healthy
controls. These authors also reported that the retrospective appraisal of TSST on visual analog
scales was unassociated with the cortisol response, while general and specific personality scales
were modestly related. Effects of stressor appraisal on cortisol response have also been
examined. Similarly, Scholtz and colleagues (2011) found greater cortisol responding to a social
stress test in healthy young men who found public speaking to be more threatening. Alexothymia
was found to be associated with significantly elevated levels of cortisol at baseline but not during
stress exposure in male college students (de Timary, Roy, Luminet, Fillée, & Mikolajczak,
2008).
To my best knowledge, only one study has examined the association between social
cognition and salivary cortisol response. Smeets and colleagues (2009) reported better
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performance on a complex social appraisal task among male college students with a higher
cortisol response to the TSST compared to those with a lower response, and men who were not
exposed to the TSST. Similarly, males with higher emotional intelligence (measured responses
to a questionnaire asking about one’s perception of his emotional intelligence) exhibited a lower
cortisol response to the TSST compared to males with lower emotional intelligence scores
(Mikolajczak, Roy, Luminet, Fillée, & de Timary, 2007). A different pattern was found among
women for whom better performance was associated with a lower cortisol response (Smeets et
al., 2009).
Cognitive effects of psycho-social stressors
Stress hormones easily permeate the blood-brain barrier and are therefore able to directly
impact cognitive processes. Stress has been found to moderate complex cognition such as dual
task performance, task switching, cognitive flexibility, creativity, estimation, and risk-related
decision-making (Allen et al., 2014). Experimentally induced stress has been demonstrated to
increase rate of false positives among semantically related distracter words on a recall task
(Payne, Nadel, Allen, Thomas, & Jacobs, 2002). Additionally, impulsivity, as measured by
performance on go-no-go paradigms, appears to increase following TSST (Scholz et al., 2009).
Performance on measures of emotional cognition has also been examined. High cortisol
responders to the TSST showed worse delayed recall for emotional and neural pictures, while
individuals without cortisol elevations in response to the TSST had improved memory for
emotionally negative pictures (Buchanan & Tranel, 2008). Similarly, TSST stress resulted in
reduced memory for emotionally neutral words, and unimpaired or enhanced recall of emotional
words and events (Jelici, Geraerts, Merckelbach, & Guerrieri, 2004; Payne et al., 2006; Smeets,
Jelicic, & Merckelbach, 2006). Others have also reported enhanced recall for material of similar
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emotional valance: studies have found reduced recall of positively charged words (Domes et al.,
2004) and enhanced memory for stressor-relevant material (Smeet et al., 2009). Overall, these
studies suggest that the effects of TSST on cognition may be moderated by emotional valiance.
Social stress tests in psychological disorders
HPA axis dysregulation has been found in schizophrenia, mood disorders, post-traumatic
stress disorder, and other psychiatric conditions and has been suggested to function as a nonspecific moderating system on symptom expression. Stress responsivity has been examined in
both clinical and non-clinical populations. While the majority of the research has been conducted
in depression, some studies have also been done with patients with bipolar disorder, healthy
adults with a history of trauma, and panic disorder. Collectively, these findings suggest that
abnormalities in endocrine response are not unique to schizophrenia, vary in their presentation,
and may be present in individuals without any diagnosable psychopathology. Alternatively, some
individuals with diagnosable psychopathology have a normalized stress response. This section
briefly reviews this spectrum of pathology with the intention of understanding the hyporesponsivity in schizophrenia on a broader scale.
Mixed findings have been reported in panic disorder ranging from non- to hyporesponsivity to the TSST. Despite exhibiting similar increases in heart rate to healthy controls in
response the TSST, cortisol values obtained during the TSST did not differ from baseline values
for all but three of the people diagnosed with panic disorder during the first TSST administration
and all but one of the patients during the second administration (Petrowski et al., 2010). These
findings were not replicated in a younger sample of individuals with panic disorder who had an
attenuated cortisol response to the TSST (Petrowski, K., Wintermann, G. B., Schaarschmidt, M.,
Bornstein, S. R., & Kirschbaum, 2013). Findings were consistent in salivary and plasma cortisol.
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Authors hypothesized that differences between studies may be due to more down regulation of
the HPA axis overtime in older patients who have had panic disorder for a longer period of time.
Cortisol responses greater exceeding baseline response were observed in adults with social
phobia in after the TSST (van Veen et al., 2009) suggesting that non-responsiveness may be not
be universal to all anxiety disorders. Due to lack of a control group, it is not clear whether these
changes were normative. Despite endorsing greater subjective distress during the TSST,
individuals with PTSD had normal cortisol responsiveness (Simeon, Knutelska, et al., 2007;
Simeon, Yehuda, et al., 2007).
Adults with a history of childhood adversity exhibit a pattern of under responsiveness to
psychosocial laboratory stressors quite similar to the one observed in schizophrenia. Elzinga and
colleagues (2007) investigated the cortisol response to the TSST in healthy undergraduate
students with a history of adverse events prior to the age of 18. Despite having elevations in heart
rate, blood pressure, and subjective stress comparable to those of healthy controls, levels of
salivary cortisol were significantly lower in people with a history of two or more traumatic
events. These findings remained significant for the overall sample and male subjects, but not for
females. Similarly, lower cortisol levels in response to laboratory psychosocial (Carpenter,
Shattuck, Tyrka, Geracioti, & Price, 2011; Kraft & Luecken, 2009; Pierrehumbert et al., 2009;
Carpenter et al., 2007) and pharmacological (Carpenter et al., 2009) challenges have been
reported in healthy adults with a history of childhood adversity including moderate to severe
childhood abuse, sexual and physical abuse, and parental divorce. Damped responsivity to
laboratory psychosocial stress tests at age 16 was associated with adversity sustained between
the ages of 12-13 and 14-15 (Bosche et al., 2012).
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Converging evidence indicates hippocampal pathology. As discussed in the previous
section, childhood adversity has been associated with disruptions in hippocampal functioning.
Additionally, similar patterns of responsivity were reported in a population of individuals with
hippocampal damage. Preliminary evidence suggests that individuals with bilateral hippocampal
lesion exhibit an attenuated cortisol response to a TSST in the context of otherwise normal
physiological responding (e.g., elevated heart rate) and levels of subjective stress (Buchanan,
Trannel, & Kirschbaum, 2009). Individual with lesions to parts of the brain other than the
hippocampus showed similar responding to healthy controls.
Investigation of cortisol response to psychosocial stressors in bipolar disorder has yielded
mixed results. Steen et al. (2011) reported attenuated cortisol response in patients with
schizophrenia and bipolar disorder in response to a mental challenge task. No differences
between the clinical populations were detected. Contrarily, Houtepen et al. (2013) found that
differences in cortisol response between healthy controls and individuals with bipolar disorder
became non-significant after including antipsychotic use a covariate in the analysis. Thus far,
studies of first degree relatives of patients with bipolar disorder have indicated normal cortisol
stress response in adult siblings (Houtepen et al., 2013) and adolescent children (Ellenbogen et
al., 2006) of individuals with bipolar disorder.
Studies of depression converge on a largely normal cortisol response to psychosocial
stress tests. Meta-analysis examining HPA axis reactivity to laboratory psychosocial challenges
concluded that patients with non-psychotic depression cannot be distinguished from healthy
controls on the basis of their stress response (Ciufolini et al., 2014). This is largely consistent
with a pervious meta-analysis of responses to stress tests in depression that reported elevations in
cortisol levels during the recovery phase of the laboratory stress tasks only (Burke, Davis, Otte,
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& Mohr, 2005). Normal stress responding has unsurprisingly also been reported in individuals
who have been in remission from depression for at least six months (Lange et al., 2013).
Impact of early adversity on HPA axis function
There is a strong association between childhood trauma and psychosis. Meta-analysis of
41 studies indicated that individuals who had experienced adversity during childhood were
almost three times more likely to exhibit psychotic symptoms than those who did not endorse
childhood adversity (Varese et al., 2012). These associations remained significant after
demographic, SES, family history of mental illness, and drug use were controlled for. Largescale studies have concluded that the relationship is causal and dose dependent: more severe or
frequent childhood abuse is associated with greater illness severity (Heins, et al., 2011; Lysaker,
Beattie, Strasburger, Davis, 2005; Read, van Os, Morrison, Ross, 2005). Similarly, individuals
with more impairing symptoms of psychosis are more likely to report more severe trauma in
childhood (Saha et al., 2011; Janssen et al., 2004). Within schizophrenia childhood trauma also
appears to interact with symptoms of schizophrenia: individuals with a history of childhood
trauma had more hospitalizations, earlier onset of the disorder, and earlier first hospitalization
(Alvarez, Oses, Foguet, Sola, Arrufat, 2011; Schenkel, Spaulding, DiLillo, Silverstein, 2005).
Psychological and biological approaches have been used to explain the link between
psychosis and childhood trauma. Psychologically, researchers have suggested that early trauma
impacts cognitive processes such as attributional biases, source-monitoring failures, dissociation,
and disruption in attachment (Morrison, 2004; Morrison, Frame, & Larkin, 2003; Morrison,
2001). Traumatic experiences have been linked the presence of negative beliefs about the self,
others, and the world.
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Models of cognitive changes following stress exposure have been examined in animals.
An animal is permanently changed by the experience of stress. As described by Weiner (1992)
animals “may learn from the experience; they may habituate with its reception; or their reaction
patterns may never again be the same.” (p. 159). Nonhuman primates with inconsistent parental
contact early in life are more fearful and submissive, and are more likely to exhibit abnormalities
in levels of key neurotransmitters such as serotonin, norepinephrine, and dopamine (Rosenblum
& Andrews, 1994; Rosenblum et al., 1994).
The findings in human literature appear to converge with the animal research: childhood
adversity has been associated with cognitive and behavioral disturbances. Studies of stress
responsivity in children with a history of trauma also support disruption at the level of
psychosocial threat appraisal and response regulation (Gunnar & Quevedo, 2007). An experience
sampling study found that individuals with a history of childhood trauma report more negative
affect and psychotic symptoms in response to everyday stressors than patients without childhood
trauma (Lardinois, Lataster, Mengelers, Van Os, & Myin-Germeys, 2011). Furthermore,
childhood trauma was found to be associated with recent adversity in a sample of psychotic
individuals (Lataster, Myin-‐Germeys, Lieb, Wittchen, & Van Os, 2012).
Experience of trauma in childhood can be particularly impactful due to increased
neuroplasticity. An interaction between sensitive developmental processes and extreme stress
can have long-term effects. Grassi-Oliveira and colleagues (2008) explain that immature
organisms try to adapt by making changes permanently, compared to mature organisms, which
tend to make temporary compensational adjustments. Thus, traumatic early experiences may
cause neurological “scars” which may underlie vulnerability to future psychopathology.
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While the mechanisms underlying stress-sensitization are not well understood, several
biological, neurobiological, and behavioral changes have been identified. Read and colleagues
(2014) published a review of the literature examining biological mechanisms linking the
experience of early adversity to psychosis that included 125 articles offering either direct
confirmation or support of the link. The traumagenic neurodevelopmental model (Read, Perry,
Moskowitz, & Connolly, 2001) posits that in some individuals early adversity leads to changes in
neurobiological stress-responsivity, which underlie the biological vulnerability to develop
symptoms of psychosis in adulthood. The 2014 review indicated that early adversity either leads
to or is associated with heighted stress sensitivity, HPA axis dysfunction, abnormalities within
the frontal lobes and hippocampus, lower levels of BDNF, increased sensitivity in
mesocorticolimbic dopamine system, and cognitive dysfunction, particularly deficits in memory
and executive functioning.
One of the mechanisms proposed to explain long-term HPA axis dysfunction is stress
desensitization. Repeated stress may cause hypersecretion of cortisol following the childhood
stressor(s), resulting in eventual desensitization of the HPA axis and leading to reduced
responsivity in the long-term (Heim et al., 2000). Childhood abuse results in increased basal
CRH levels, which lead to decreased pituitary sensitivity to CRH stimulation through downregulation of CRH receptors (Grassi-Oliveira, Ashy, & Stein, 2008). Long-term CRH elevations
lead to a relative adrenal insufficiency.
Schizophrenia
As previously mentioned, the HPA axis has been investigated as the set of biological
structures that mediate the relationship between stress and risk for developing mental illness. The
HPA axis has also been proposed to trigger the series of biological events that contribute to the

23

emergence of psychotic symptoms, particularly positive symptoms (Walker, Mittal, & Tessner,
2008; Holtzman et al., 2013)). Gispen-Wied and colleagues (2000) note inconsistencies in the
schizophrenia literature, as some studies report intact baseline cortisol levels, while others report
evidence of hypercortisolemia in schizophrenia patients. Examination of cortisol in response to
laboratory stressors has yielded more consistent findings.
Baseline HPA axis function
Given the fact that the HPA axis plays a major role in homeostasis, understanding diurnal
rhythm has been of great interest. Baseline activity is a measure of HPA axis functioning outside
of an immediate stressor. An organism’s set points can change depending on its experience,
therefore the term “baseline” must be considered in the context of one’s history (Danese &
McEwen 2012).
In an effort to understand the diurnal rhythm of cortisol secretion in schizophrenia,
measures of cortisol have been taken at various time points during the day including morning,
afternoon, and evening. Both blunted cortisol awakening response (CAR) and elevated levels of
cortisol in schizophrenia have been reported in the morning (Girshkin, Matheson, Shepherd, &
Green, 2014; Monteleone et al., 2014; Mondelli et al., 2010; Braehler et al, 2005). Elevations
have also been reported in afternoon cortisol levels (Gallagher et al., 2007; Walsh et al., 2005;
Ryan et al., 2004). Evidence suggests that hypercortesolimia predates onset of the disorder itself:
Higher levels of cortisol have also been reported in a large sample of people who are at elevated
risk of developing psychotic disorder (Walker et al., 2013) and in unaffected siblings of
individuals with schizophrenia relative to healthy controls (Collip et al., 2011).
Meta-analysis of 64 studies of morning cortisol levels in schizophrenia and bipolar
disorder concluded that there is moderate quality evidence of small to moderate elevations in
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peripheral morning cortisol levels in both disorders relative to healthy controls, without
significant differences between the two disorders (Girshkin, et al., 2014). In contrast to the CAR,
which is a naturally occurring peak in cortisol occurring within the first 30-40 minutes after
awakening, morning cortisol levels and has been argued to be a reaction to the mild stressor of
waking up, which are sampled immediately after awakening reflect basal cortisol levels (Clow,
Thorn, Evans, & Hucklebridge, 2004; Wust et al., 2000). Greater effect sizes in schizophrenia
were reported for patients who are currently hospitalized, unmedicated, and those who have had
more than one psychotic episode. While the majority of findings indicate similar levels of
baseline cortisol between the genders (Girshkin et al., 2014; Mondelli et al., 2010), at least one
study has found attenuations in men only (Pruessner et al., 2008).
Different correlations between diurnal cortisol levels were found in patients in healthy
controls: in patients diurnal cortisol levels were negatively correlated with the number of recent
stressors, while in healthy controls there was a positive association (Modelli et al., 2010). This
study also found that awakening cortisol levels were blunted in the patients with first episode
psychosis (FEP) irrespective of medication status relative to healthy controls. Awakening
cortisol was positively correlated with history of childhood sexual abuse.
Acute use of anti-psychotics, particularly atypical ones, tends to decrease cortisol levels,
an effect that appears to normalize with chronic use. Attenuated levels of plasma cortisol have
been observed in healthy controls following administration of antipsychotic medications (Cohrs
et al., 2006). Further evidence comes from comparing populations of schizophrenia patients:
hypercortesolemia has been reported in unmedicated FEP patients (Ryan et al., 2004) and
Modelli et al. (2010) reported that FEP patients with less than two weeks of treatment with
atypical antipsychotics had higher diurnal levels of cortisol than FEP patients with two or more
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weeks of treatment and healthy controls. No differences were reported between the latter groups,
suggesting that two weeks of treatment may normalize morning hypercortisolemia. Chronic use
of anti-psychotic medications cease to lower cortisol levels (Meador-Woodruff & Greden, 1998),
as evidenced by studies of medicated and chronic schizophrenia patients have also reported
elevations in baseline cortisol levels (Gallagher et al., 2007; Yilmaz et al., 2007). Others have
reported normal cortisol levels in schizophrenia patients on and off medications (Rao et al.,
1995), suggesting that differences may be due to disorder related heterogeneity.
Possible interpretations of HPA hyperactivity include results of chronic HPA axis
dysregulation, compounding effects of illness, or fluctuations related to illness exacerbation. It
has also been proposed that elevations in basal levels of cortisol are the result of an
endophenotypic marker of illness (Cheng et al., 2010). Others have hypothesized elevations may
be due to symptoms of depression or negative symptoms (Gispen-de Weid, 2000). Overall,
findings regarding baseline levels of cortisol in schizophrenia remain mixed as several studies
have reported cortisol values that are within normal limits (Jansen et al., 2000; Rae et al., 1995;
Roy et al., 1986; Kemali et al., 1985), suggesting that further research is warranted.
Challenge Tests
Unlike passive measures of baseline functioning, challenge tests investigate HPA axis
functioning in response to a stressor. This type of testing has been argued to be more sensitive,
representative of HPA axis functioning, and a better indicator of HPA axis dysfunction
(Holsboer, 2001). As previously discussed, challenge tests may be in the form of
pharmacological, physical, and psychosocial.
DST studies have been used to investigate HPA axis functioning in schizophrenia. Metaanalyses of 34 studies DST studies in schizophrenia reported that patients have significantly
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higher rates (26.4%) of non-suppression (defined as responding above a cut-off value of 5
mcg/dL of cortisol the morning following administration) when administered 1-mg of
dexamethasone compared to healthy controls (5.0%) and have greater variability of nonsuppression values (Yeragani, 1990). This meta-analysis did not find relationships between nonsuppression and symptoms of depression, severity of positive symptoms, or schizophrenia subtype. Tandon and colleagues (1991) reported that 39% of the 44 individuals who were admitted
for inpatient treatment of schizophrenia were DST non-suppressors. These patients were off
medications for a minimum of two weeks prior to study participation. Following four weeks of
treatment using clinically determined doses of typical antipsychotic medications, 14% of the
sample remained non-suppressors. Similarly, a study of FEP male patients found that acute
treatment lowered the percentage of non-suppressors from 14% of the total sample to 5%
(Ceskova, Kasparek, Zourkova, & Prikryl, 2006). These findings have not been replicated in
chronic schizophrenia. Ismali and colleagues (1998) did not find non-suppressors in a sample of
medicated schizophrenia patients and similar levels of salivary cortisol were found following
DST in healthy controls and schizophrenia patients (Jansen et al., 2000). Similarly, in a mixed
sample of schizophrenia patients, 38% of the sample were non-responders, the majority of whom
were unmediated (Lammers et al., 1995). Together these findings suggest that DST nonsuppression may be responsive to pharmacological intervention, or is associated with acute
distress in schizophrenia.
Other pharmacological challenge tests have indicated normal responsivity in
schizophrenia. Jansen and colleagues (2000) did not find differences between people with
schizophrenia and controls in cortisol levels following dexamethasone ingestion and
hydrocortisone. Both tests were used because they reflect different aspects of HPA axis
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functioning: dexamethasone is mainly active at the pituitary level while hydrocortisone has
more affinity for supra-pituitary glucocorticoid receptors (De Kloet, 1991). Similarly, metabolic
stress induced by 2-deoxy-D-glucose (2DG), a glucose analog that impairs glucose metabolism
and causes a state similar to hypoglycemia, caused similar cortisol elevations in patients with
schizophrenia and healthy controls (Ellman et al., 1998; Kathol et al., 1993; Breier & Buchanan,
1992). Additionally, m-chloropheylpeperazine, a serotonin agonist that directly stimulates the
HPA axis, induced a normal increase of pituitary-adrenal hormones (Kahn, Davidson, Siever,
Sevy, & Davis, 1994).
One challenge in interpreting studies that utilize laboratory-based stressors to modify
cortisol levels is that differential activation of the HPA axis occurs depending on unique
characteristics of the stressor. For physical stressors, proxies of the exteroceptive stress system
functioning, the most important factor is that stimuli intensity, while for psychological stressors,
proxies of the interoceptive stress system, greater unpredictability, ego-involvement, novelty,
and less controllability of the task will elicit a stronger HPA axis response (Gispen-de Wied,
2000). The following section will examine laboratory stressors by grouping them their
respective dichotomy.
There have been few studies examining cortisol response to physical stressors in
schizophrenia, and those that have been conducted have yielded mixed findings. Intact cortisol
levels were observed following a physical exercise on a stationary bike (Jansen et al., 2000).
Studies examining stress response due to medical procedures, however, have consistently found
attenuation in response to surgical stress (Kudoh, Ishihara, & Matsuki, 1999; Kudoh, Kudo, &
Ishihara, 1997), and lumbar puncture (Breier, Wolkowitz, Doran, Bellar, & Pickar, 1988). Thus,
it may difficult to generalize, as it is not clear how anesthetics may interact with antipsychotic
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medications. One study has reported greater cortisol stress responding in schizophrenia. Patients
with primarily paranoid symptoms demonstrated an overall elevation in cortisol in response to a
cold presser test, active relaxation, noise test, and mental calculation relative to healthy controls
(Albus, Ackenheil, Engel, & Müller, 1982). This study is somewhat difficult to interpret as
authors have confounded the effects of physiologically and physically stressful events.
Given the mixed finding, results of studies of examining cortisol stress responding to
mental and social stressors have yielded surprisingly consistent findings. Laboratory studies of
HPA axis responsivity in schizophrenia found attenuated levels of cortisol in response to
psychosocial stressors. To date three in-vivo studies examining social stress response have been
conducted in schizophrenia (Brenner et al., 2009; Jansen, Gispen-de Wied, & Kahn, 2000;
Jansen et al., 1998) and one examining cortisol response to a test of mental arithmetic (Steen et
al., 2011), one study in first episode psychosis (van Venrooij et al., 2012), and one study in
people at ultra high risk (UHR) for developing psychosis (Pruessner et al., 2013). Despite
methodological differences, the findings are consistent: four studies found attenuated cortisol
levels in response to the stressor in the clinical populations compared to healthy controls
(Pruessner et al., 2013; Steen et al., 2011; van Venrooij et al., 2012; Jansen, Gispen-de Wied, &
Kahn, 2000; Jansen et al., 1998). One study reported significantly lower cortisol values in
schizophrenia for four of the time points examined (baseline, anticipatory, immediately after
stressor and 15 minutes after the stressor) in male subjects only (Brenner et al., 2009). A metaanalysis of three studies of laboratory social stress tests (Van Venrooij et al., 2012; Brenner et
al., 2011; Jansen et al., 2000) revealed that relative to healthy controls, schizophrenia subjects
had lower levels of cortisol during the anticipatory phase and lower peak cortisol levels;
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however, no significant differences in the recovery phase of the social stress test or in overall
change in cortisol levels were found (Ciufolini, Dazzan, Kempton, Pariante, & Mondelli, 2014).
Holtzman and colleagues (2013) proposed three explanations to account for the
dampened cortisol response when faced with social stressors: 1) ceiling effects on cortisol
production; 2) experiencing external factors as less stressful after onset of psychosis; and 3) the
psychosocial events that are threatening may become idiosyncratic. Each of the explanations are
examined below.
It does not appear that there are ceiling effects in cortisol production in schizophrenia.
The authors of meta-analytic study ruled out this possibility based on the fact that change in
cortisol (difference between lowest values and peak values) and variability for all time points
except the task recovery were equal for patients and controls (Ciufolini, et al., 2014). The metaanalysis did find a significant difference between healthy controls and schizophrenia patients in
peak cortisol values during the laboratory social stressor was reported, which may be indicative
of some differences of ceiling effects. van Venrooij et al. (2012) did not find differences in peak
values between patients and controls. Unfortunately, analyses of differences in peak values were
not reported in the other articles. Another potential confound is the fact that these studies were
not conducted in front of a live panel, which, as previously mentioned, has been associated with
significantly greater cortisol response compared to imagine panels (Kelly et al., 2007) and two of
the studies recruited both males and females.
There is no empirical evidence to support the second claim, or that patients experience
external events as less stressful. Patients’ subjective ratings of anxiety and stress prior to and
during the social stress tests are equal to or greater than those of healthy controls (van Venrooij
et al., 2012; Jansen et al., 1998). Additionally, measures of autonomic activation were either
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comparable or higher for patients than healthy controls, including increases in heart rate, and
mean arterial pressure (van Venrooij et al., 2012; Brenner et al., 2009; Jansen et al., 1998).
Patients reported experiencing significantly less control while speaking in public (van Venrooij
et al., 2010), which is generally associated with increased anxiety, and endorsed the use of more
confrontational and avoidant coping strategies during the psychosocial stressors than healthy
controls (Jansen et al., 2000). These findings are consistent with other studies that found that
individuals diagnosed with schizophrenia are more likely to perceive both positive and negative
events as more stressful, less controllable, and are more likely to report that they handled the
stressful situation poorly compared to healthy controls (Horan et al., 2005). Jointly these
findings indicate that there may be differences in the subjective experience that may affect
neurobiological regulation of the stress response; however, current evidence suggests that
patients with schizophrenia experience more stress than healthy controls in the similar situations.
Finally, the third explanation, or that psychosocial events may become idiosyncratic for
individuals with schizophrenia, has not been directly tested as it does not propose a hypothesis
for how the idiosyncrasies are expected to impact HPA functioning.
One study that examined the relationship between current positive symptoms and cortisol
response to a psychosocial stressor did not find a significant association (Jensen et al., 1998).
Additionally, the fact that dampened responsivity was reported in first episode schizophrenia
patients in a psychiatric hospital (van Venrooij et al., 2012), clinically stable chronic
schizophrenia outpatients (Jansen et al., 1998, 2000), and UHR individuals who have never been
psychotic (participants included on the basis of attenuated psychosis), would suggest that
psychosis alone cannot account for this finding.
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Furthermore, attenuated cortisol response to psychosocial stressors does not appear to be
due to disease-chronicity or use of antipsychotic medications. As stated previously, attenuated
cortisol levels were reported first episode patients and individuals who are UHR ( Pruessner et
al., 2013; van Venrooij et al., 2012). Both groups are naïve to antipsychotic medication,
suggesting that the differences in the cortisol response to psychosocial stress test predate medical
usage.
This small body of literature is not without limitations. One confound in this research is
smoking. Long-term nicotine dampens HPA axis responsivity (Kudilka, Hellhammer, & Wüst
2009), which is particularly concerning for this population given the high prevalence of smoking
in schizophrenia. For example, one study found that 88% of individuals with schizophrenia
smoke (Mitchell & Dahlgren, 1986), and rates of smoking in schizophrenia have been estimated
to be 2-3 times higher than the general population (Kelly & McCreadie, 2000). van Venrooij and
colleagues (2012) recruited nonsmoking controls, which increases the probability of finding a
significant difference between the groups given that half of the schizophrenia sample smoked.
This concern is somewhat mitigated by the fact that comparison of peak cortisol values of the
smoking and non-smoking patients was non-significant. Pruessner et al.’s (2013) study of UHR
subjects suggests that the attenuated responding is not due to smoking given that there were
equally small numbers (3/21) of smokers in the UHR and healthy control samples, and that longterm smoking is less likely in this younger sample of subjects (mean age of subjects was about
20). Smoking status was not reported by the other studies (Jansen et al., 1998, 2000; Brenner et
al., 2009).
Another complication is the use of mixed gender samples. Three of the studies
(Pruessner et al., 2013; Brenner et al, 2008; Jansen, 2000;) used mixed gender samples and did
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not correct for menstrual phase or report use of oral contraceptives. A large-scale review
(Kanjantie & Philips, 2006) concluded that adult females generally show lower HPA axis
responsiveness than men, greater responding during the luteal phase, and lower levels of salivary
cortisol in women using oral birth control. Additionally, experimental manipulation of the
stressful social situation has found differences in factors that impact responding in the genders
(e.g., Smeets et al., 2009), suggesting that triggers may differ.
Therefore, it is possible that averaging across genders may obscure significant findings between
groups and misrepresent the relationship between cortisol levels and other psychosocial variables
of interest.
There is some evidence to support the hypothesis that predictors of cortisol response are
different for people with schizophrenia and healthy controls. Coping style and stress reactivity
explained an additional 20% of the variance in quality of life for schizophrenia but not healthy
controls and that lower levels of cortisol in response to the TSST were associated with a higher
self-reported quality of life in schizophrenia (Brenner et al., 2011). Pruessner and colleagues
(2013) reported lower overall cortisol release during the TSST to be associated with higher selfreported stress over the past year in UHR participants but not healthy controls. Self-reported
stress was measured by a single rating on a Likert scale from “not stressed” to “very stressed” in
response to, “How stressed did you feel in the last year?” No associations were found between
cortisol release, subjective stress during the task, or subjective stress during the last month.
Additionally, those who rated the TSST to be more stressful tended to have lower self-esteem
and reported use of fewer coping strategies.
Evidence suggests that there may be differences in subjective experience during the
psychosocial stress test. Male first episode schizophrenia patients and controls were found to
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have experienced similar levels of stress in the past month (van Venrooij et al., 2010). Patients
reported higher levels of anxiety than controls during the task as measured by the Spielberger
State Train Anxiety Inventory. Ten-point visual analogue scales found no differences between
patients and controls in terms of nervousness before or during the TSST, or the level of
experienced control during the preparation phase. Patients were more nervous after the public
speaking task and reported experiencing less control during the task than healthy controls. This
finding was not always replicated despite the similarity in methodology. Similar ratings of
anxiety were obtained in schizophrenia and healthy controls when asked to rate the stressfulness
of the task (1= not stressed at all, 10=extremely stressed) (Brenner et al., 2009) and on the STAI
(Jansen et al., 2000).
Only one schizophrenia study has examined the relationship between self-reported coping
behaviors used during the TSST and the stress response. Trend level negative associations
between self-reported use of escape/avoidance coping during the TSST and cortisol response was
observed for the overall sample. Reported tendency to use passive coping strategies in day-today life was negatively correlated with cortisol and people with schizophrenia reported using
more confrontive coping and escape/avoidance coping than healthy controls during the TSST.
Previous study found that males with schizophrenia reported using more avoidant and passive
coping strategies than healthy controls in a hypothetical social situation; however, no difference
in coping strategy was found in problem solving a hypothetical non-social situation (Jansen et
al., 1998). This suggests that people with schizophrenia may have both physiological and
psychological difficulty coping with socially stressful situations.
Social cognition in schizophrenia
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Social cognition is broadly defined as the mental operations that underlie social
interactions. Attendees of a National Institute of Mental Health Workshop focused on social
cognition in schizophrenia used the following definition of social cognition: “the mental
operations that underlie social interactions, including perceiving, interpreting, and generating
responses to the intentions, dispositions, and behaviors of others” (Pinkham et al., 2013). A focus
group of researchers examining social cognition in schizophrenia concluded that research can be
divided into five partially-overlapping domains: theory of mind, social perception, social
knowledge, attributional bias, and emotional processing (Green et al., 2008).
Impairments in social cognition are a defining feature of schizophrenia. Deficits in social
cognition are often evident prior to illness onset and are more prevalent among non-affected
first-degree relatives of people with schizophrenia compared to those without affected first
degree relatives (Hans, Aurbach, Asarnow, Styr, & Marcus 2000; Dworkin, et al., 1993). Social
cognition is conceptualized to be semi-independent of cognition, and its domains are
differentially impacted (Silver, Bilker, Goodman, 2009; Mancuso, Horan, Kern, & Green, 2011).
Impairments in social cognition have been linked to lower functional and occupational
functioning and lower quality of life (Horan et al., 2011; Fett, Viechtbauer, Penn, van Os, &
Krabbendam, 2011; Bell, Tsang, Grieg, & Bryson, 2009; Couture, Penn, & Roberts, 2006;
Brune, 2005). It has also been observed that improvements in social cognition following
specialized training are associated with improvements in day-to-day social functioning, social
skills, relationships, and enhanced social adjustment (Eack, Greenwald, Hogarty, Keshavan,
2010; Combs, Adams, Penn, Roberts, Tiegreen, & Stem, 2007).
Studies of emotional processing found that people with schizophrenia experience higher
levels of negative emotion than healthy controls and find social interactions to be less enjoyable.
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Naturalistic studies of day-to-day experience such as random experience sampling have been
used to examine self-reported emotions outside of the laboratory setting. People with
schizophrenia were found to have more intense and variable negative emotions than healthy
controls (Myin-Germeys, Delespaul, & deVries, 2000). Gard and Kring (2009) reported that
while overall levels of emotion experienced are comparable, people with schizophrenia
experience social interactions to be less pleasant and more activating compared to healthy
controls. Similarly, patients reported more withdrawal and desire to be alone when around others
compared to healthy controls (Oorschot, et al., 2011). A meta-analysis of naturalistic studies
concluded that individuals with schizophrenia report more negative feelings following stressful
situations compared to patients with depression, bipolar disorder, unaffected relative of a person
with schizophrenia, and healthy controls (Kring & Moran, 2008). Furthermore, these findings are
consistent with a meta-analysis of 26 laboratory-based studies of emotional experience in
schizophrenia which found that patients report higher levels of aversion in response to both
positive and negative stimuli (Cohen & Minor, 2011).
The evidence for difference in both appraisal and experience of social situations in
schizophrenia suggests the need for better understanding of the experience of the TSST in
schizophrenia. Jones and Fernyhough (2007) pointed out that the diathesis-stress model proposed
by Walker & Diforio (1997) did not address how the subjective experience of a stressor impacts
physiological response. The authors were particularly interested to know if the literature based
on healthy controls (or the importance of social threat and uncontrollability) will extend to the
schizophrenia population.
Hypotheses
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Hypothesis I: Based on previous research, it is hypothesized that individuals with
schizophrenia will exhibit small increases in cortisol relative to healthy controls. Conversely,
group differences are not expected in heart rate and rating of negative emotions on the VAS.
Task appraisal differences are expected to emerge when examining the PASA; it is hypothesized
that the SZ group will have a higher primary appraisal and lower secondary appraisal of the
TSST.
Hypothesis II: It is hypothesized that people with schizophrenia who have better social
cognition will have a greater cortisol response to the psychosocial stressor, while healthy
controls with better social cognition will have a smaller cortisol response.
Similarly, it is hypothesized that better performance on a test of everyday skills will be
positively related to cortisol response for the SZ group, and the opposite relationship will be
observed in the HC group.
Hypothesis III: It is also hypothesized that the prevalence of childhood adversity would
be greater in the schizophrenia group than among the healthy controls. Lastly, it is hypothesized
that individuals who report more childhood adversity will respond with lower levels of cortisol to
the social stress test across the sample. It is also hypothesized that childhood sexual abuse will
account for a greater portion of variance in in the cortisol released than other forms of abuse
sustained during childhood.
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CHAPTER 3
METHODS
Participants
Thirty-six participants enrolled in the study. Three healthy controls were excluded from
the study. One healthy control gave minimal effort as was determined by poor performance,
another healthy control reported that he was recently diagnosed with adrenal fatigue, and the
third healthy control was uncooperative. These participants were paid for the time they spent
working in the laboratory and dismissed from further participation. Thirty-three men between the
ages of 18 and 65 were included in the present study. Sixteen people were diagnosed with
schizophrenia or schizoaffective disorder, and seventeen people were healthy controls. The
sample consisted of only males because previous findings indicate that females have a distinct
hormonal response to stressors (Kirschbaum et al., 1999) and a different relationship between
hormonal response and social cognition than males (Wadiwalla, et al., 2010; Smeets et al., 2009;
Andrews et al., 2007). Together these findings suggest that generalizability between the genders
is limited; therefore, the current study focused on investigating the response found in males to
reduce variability in the data.
Study exclusion criteria consisted of: history of traumatic brain injury, history of electroshock therapy, inability to provide informed consent, English is not the primary language,
inability to comprehend the current testing battery, history of substance abuse or dependence in
the past six months, or were unable to participate due to sensory impairments. Individuals with
medical illness known to affect functioning of the central nervous system or conditions that are
known to cause disturbances in HPA axis functioning were also excluded. Additionally, healthy
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controls were excluded if they had a family history positive for one or more first-degree relatives
with schizophrenia or bipolar disorder.
Measures
Several domains of functioning were measured including: clinical symptoms, social
cognition, functional capacity, estimated intelligence and cognitive functioning, and self-report
measures that examine stress response and history of trauma. Additionally, there were several
outcome measures used to assess stress response associated with the Trier Social Stress Test
(TSST).
Clinical Symptom Measures. These instruments were used to confirm study eligibility
and measure current symptom levels.
Structured Clinical Interview for DSM-IV. Individuals with schizophrenia were
diagnosed with schizophrenia by their treating clinician. Clinical diagnoses were confirmed
using the Structured Clinical Interview for DSM-IV (SCID; First, Gibbon, Spitzer, & Williams,
2002). The SCID was also used to ensure that the healthy controls did not meet criteria for any
mental health diagnosis in the last year or a lifetime diagnosis of schizophrenia or bipolar
disorder. The SCID is designed to identify clinical symptoms and determine diagnoses that meet
criteria for psychopathology. Criteria from the DSM 5 (American Psychiatric Association, 2013)
were also consulted.
Brief Psychiatric Rating Scale. The Brief Psychiatric Rating Scale (BPRS; Overall &
Gorham, 1962) consists of 18 clinician rated items designed to measure several aspects of
psychopathology including mood, disorganization, anxiety, and positive and negative psychotic
symptoms. The ratings were made based on answers to a semi-structured interview that asked
about the previous two weeks’ worth of functioning, and behavioral observations made during

39

interview. Each item is rated on a scale of 1 to 7 (absent to extremely severe). A total score is
derived by summing up all of the items.
Scale of Assessment of Positive Symptoms. The Scale for the Assessment of Positive
Symptoms (SAPS; Andreasen, 1984) is a 34-item clinician rated scale that assesses positive
symptoms including, hallucinations, delusions, thought disorder, bizarre behavior, and formal
thought disorder on a scale of 0 to 5 (absent to severe). Global ratings for each domain evaluate
the overall severity of the symptom. The scores are based on the participant’s report of presence
of the symptom in the past two weeks and behavioral observations during the interview. Adding
the 34 items produces a total score reflecting an overall level of positive symptoms.
Scale of Assessment of Negative Symptoms. The Scale for Assessment of Negative
Symptoms (SANS; Andreasen, 1983) is a 30 item clinician-rated scale designed to measure
negative symptoms across the following domains: affective flattening, alogia, avolitionasociality, anhedonia, and attentional impairment. Global ratings are made to assess the overall
severity of each of the domains, a total sum of all of the items administered indicating overall
severity.
Estimated Intelligence and other Measures of Cognition. Three subtests from the
Wechsler Adult Intelligence Scale, third edition (WAIS-III; Wechsler, 1997) were used to
calculate an estimated current intelligence. Those three subtests are: Block Design (BD),
Vocabulary (VO), and Matrix Reasoning (MR). The regression equation used to estimate current
full scale IQ is (VO Scaled Score x 2.727) + (BD Scaled Score x 2.727) + 42.535 (Schoenberg,
Scott, Duff, & Adams, 2010).
WAIS-III Block Design Subtest. The Block Design subtest (Wechsler, 1997) is a test of
perceptual reasoning. This subtest asks the respondent to assemble red and while blocks to match
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images of increasing complexity within a time limit. This is a test of perceptual reasoning. Points
were awarded for correct completions within the time limit and the points are summed to obtain
a total raw score. Raw scores are then converted to age-corrected scaled scores.
WAIS-III Vocabulary Subtest. The Vocabulary subtest (Wechsler, 1997) assesses the
crystalized ability of vocabulary knowledge. This test asks respondents to define increasingly
complex words and awards points for correct responses. Total points earned are summed
together and converted to age-corrected scaled scores.
WAIS-III Matrix Reasoning Subtest. The Matrix Reasoning subtest (Wechsler, 1997)
assesses perceptual reasoning by asking respondents to solve visual puzzles by selecting the
missing piece from a set of potential responses. Raw scores are converted to age-corrected scaled
scores.
Social Cognition. Measures were used to assess various aspects of social cognition and
functioning.
Reading of the Mind in the Eyes Test. The Eyes Test (Baron-Cohen et al., 2001) is a
test of one’s ability to accurately determine the expression communicated by a set of eyes. The
participant was asked to select one adjective from four options that most closely matches the
emotion communicated by a narrowly cropped eye region. The participant is awarded a point for
the correct response and does not receive feedback about the accuracy of the selection made. The
total number of items answered correctly was used as the outcome variable for the current study.
Hinting Task. The Hinting Task (Corcoran et al., 1995) consists of ten social scenarios
that are read aloud and requires that participants to inter the implied intention of a character in a
social scenario. The participant is read a scenario where one of the characters states a need
indirectly and is then asked to explicitly state what the implied intent is. If the respondent gets a
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question either fully or partially wrong, designated prompts are provided that allow the
participant an opportunity to earn additional credit. This assessment does not have a discontinue
criteria therefore all items were administered.
WAIS-III Picture Arrangement. The WAIS-III Picture Arrangement (PA) subset
consists of pictures of characters in ten social scenarios. Participants are asked to find the logical
order for each set of cards that would convey a coherent story. Each set of cards is increasingly
more difficulty than the previous set of cards and participants receive credit for only correctly
arranged sets. PA is sensitive to social cognition deficits in schizophrenia and bipolar disorder
(Thaler et al., 2013). Raw score of correctly arranged sets were used.
Functional Capacity. Functional capacity, or ability to attend to day-to-day
responsibilities, was assessed using.
UCSD Performance Based Skills Assessment. The UCSD Performance Based Skills
Assessment (UPSA; Patterson, Goldman, McKibbin, Hughs, & Jeste, 2001) is a laboratory
measure of day-to-day functioning. This measure assesses functioning across five domains:
planning recreational activities, finance, communication, transportation, and house hold chores.
Each of the subscales yields a raw score, which was transformed into a percentage and then
multiplied by 20 to contribute proportionally to a total score. The five scores are then added
together to yield a total score ranging from 0-100.
This instrument was developed to for assessment of psychiatric populations. Impaired
performance has been reported among people with schizophrenia (Vogel, 2015).
Self-Report Questionnaires. Self-report questionnaires were used to examine trauma
history, stress reactivity, and defeatist beliefs.
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Childhood Trauma Questionnaire. The Childhood Trauma Questionnaire (CTQ;
Bernstein et al., 2003) is a 28-item self-report questionnaire that assesses childhood trauma,
including emotional, physical, and sexual abuse, and emotional and physical neglect.
Additionally, three questions assess potential Minimization/Denial. The scale consists of five
items per abuse type that are rated on a 5 point Likert scale ranging from 0 to 4 (never true to
very often true). The total score per trauma type was used in further analysis. Studies have
demonstrated comparable reliability of report of childhood abuse for individuals with psychiatric
diagnosis and healthy controls (Read et al., 2005).
Life Events Checklist. The Life Events Checklist (LEC; Gray, Litz, Hsu, & Lombardo,
2004) has a list of 16 different and potentially traumatic life events that are often associated with
PTSD. The LEC was used to identify potentially traumatic events experienced by the participant
during his lifetime, allowing for the comparison of overall traumatic events that one has been
subjected to personally, witnessed, or learned about. Additional options of “not sure” and
“doesn’t apply” are also included. Total number of items endorsed per category was included in
analyses.
Defeatist Performance Beliefs from the Dysfunctional Attitudes Scale. The Defeatist
Performance Beliefs (DPB) is a subscale of the Dysfunctional Attitudes Scale (DAS; Weissman,
1978). This measure consists of 15 mal-adaptive beliefs (e.g., “It is difficult to be happy unless
one is good looking, intelligent, rich, and creative.”) and asks participants to rate to what extent
they agree with each item on a scale of 1 (Agree Totally) to 7 (Totally Disagree). The items are
reverse scored, therefore lower scores on the DPB correspond with lower rates of defeatist
beliefs, and the sum of all of the responses is the total score.
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Perceived Stress Reactivity Scale. Perceived response to common and potentially
stressful situations was measured by the Perceived Stress Reactivity Scale (PSRS; Schlotz, et al.,
2011). This questionnaire presents a stressful scenario (e.g., “When others criticize me…”) and
asks respondents to select the response that most closely resembles their reaction to stress from
three options. Higher scores correspond to higher perceived stress reactivity. The PSRS measures
Perceived Reactivity to Work Overload (WO), Perceived Reactivity to Social Conflicts (SC),
Perceived Reactivity to Failure (FA), Perceived Reactivity to Social Evaluation (SE), and
Prolonged Reactivity (Pro).
Toronto Alexithymia Scale-20. Alexithymia, or the inability to understand and/or
articulate one’s own emotional experience, was assessed using the Toronto Alexithymia Scale-20
(TAS-20; Bagby, Parker, & Taylor, 1994). The TAS-20 is a self-report questionnaire consisting
of 20 items that answered on a scale of 1 to 5 (ranging from Strongly Disagree to Strongly
Agree). The items assess three dimensions: 1) Difficulty Identifying Feelings (DIFF) for
example, “I am often confused about the emotion I am feeling” 2) Difficulty Describing Feelings
(DEF) for example, “It is difficult for me to find the right words for my feelings”; and 3)
Externally Oriented Thinking (EOT) for example, “I find examination of my feelings useful in
solving personal problems.” Five of the items on this scale were reverse scored. Scores
contributing to each dimension were added together.
With respect to background and applicability, this version of the scale was created to
address the psychometric shortcomings of a pervious version. The revision was based on the
responses of 965 individuals and yielded a measure with good internal consistency, test-re-test
reliability, and a factor structure consistent with the construct of alexithymia. Stable factor
structure was reported for healthy controls and psychiatric outpatients (Loas et al., 2001; Bagby,
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Parker, & Taylor, 1994); however, at least one discrepant factor structure was reported for a
sample of 76 outpatients with schizophrenia (Maggini & Raballo, 2004). Additionally, the TAS20 has been used to investigate schizophrenia and has been found to be associated with symptom
severity and verbal abilities (Cedro et al., 2000; Stanghellini, G., & Ricca, V., 1995).
Measures used to Evaluate Response to Experimental Stressor. Procedures used to
evaluate response to the Trier Social Stress Test included evaluations of emotion using a visual
analogue scale, measurement of heart rate, and the Primary Appraisal Secondary Appraisal
Scale.
Visual Analogue Scale (VAS). Participants were provided a page with 5 emotions
(Nervous, Scared, Calm, Excited, Happy) with corresponding 15-centimeter lines where they
were asked to indicate the intensity of each emotion ranging from “Not at all” to “Extremely.”
The VAS scale can be found in the Appendix. Because cortisol is main outcome variable and
time point 9 was only collected for participants who had additional measures to complete in the
laboratory, heart rate and VAS scales were not administered at time point 9.
Primary Appraisal Secondary Appraisal Scale. The Primary Appraisal Secondary
Appraisal Scale (PASA; Gaab et al., 2005) is a 16 item self-report measure based on the
transaction stress theory, which is used to assess the cognitive appraisal of the TSST. This
measure examines primary appraisal, or one’s impression of a given task’s demands, and
secondary appraisal, or the perception of one’s resources and abilities to meet the demands of the
task. The PASA was administered after the TSST was explained. Participants were asked to
make their ratings on a six point Likert scale with ranging from 1, or Completely Disagree, to 6,
or Complete Agree. These indices were found to have good internal consistency (Gaab et al.,
2005).
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The PASA has four primary scales: Perceived Threat (e.g., “I do not feel threatened by
the situation”), Challenge (e.g., “The situation is important to me”), Self-Efficacy (e.g., “In this
situation I know what I can do”); and Expectation of Control (e.g., “It mainly depends on me
whether the experts judge me positively”). Additionally the secondary scales of Primary
Appraisal (PA), or the sum of Perceived Threat and Challenge indices, and Secondary Appraisal
(SA), or the sum of Self-Efficacy and Expectation of Control, can be calculated. Lastly, Tertiary
Scale termed the Stress Index (SI) can be determined. The SI uses the following formula: PA –
SA.
The primary appraisal scales of the PASA were found to account for significant portions
of the cortisol stress response for a sample of physically and psychiatrically healthy male
university students. Interestingly, secondary appraisal indices were not found to be significant
(Gaab et al., 2005).
Salivary sampling. Saliva samples were collected before the TSST and at designated
time points during the TSST. Study participants were asked to keep a SalivaBio Oral Swab
(SOS) under their tongues for 90-120 seconds, a time frame recommended for saturation of the
SOS. The participants were then instructed to place the SOS into a swab storage tube, which was
then placed in a sample container bag. The samples were refrigerated until the end the
experiment, at which point all of the samples were transported and stored at -20°C until they
were processed. The samples were assayed using Salimetrics cortisol enzyme immunoassay
(Salimeterics LLC, State College, PA) per the instructions provided by the manufacturer that can
be found here: https://www.salimetrics.com/assets/documents/1-3002n.pdf.
Samples stored in -20C were thawed at room temperature, vortexed, and then centrifuged
at 1500x g for 15 minutes. Each plate included 25 uL of standards, controls, and saliva in their
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respective wells and all were run in duplicate. Additionally, non-specific binding (NSB) wells
were included on each plate to serve as the blank when calculating cortisol concentration from
the optical density values. 200 uL of Enzyme Conjugate was added to each well and then mixed
on a plate rotator for five minutes at 500 rpm followed by 55 minutes of room temperature
incubation without shaking. Each plate was then washed four times with a 1X wash buffer and
thoroughly tamped between each wash. Following the washes, 200 µL of Substrate Solution was
added to each well and mixed on a rotator for five minutes at 500 rpm and then incubated in the
dark at room temperature for an additional 25 minutes. Finally, 50 µL of Stop Solution was
added to each well and mixed at 500 rpm for three minutes. Plates were read at 450 nm within 10
minutes of adding the Stop Solution. To calculate the cortisol concentrations, the NSB wells
were subtracted from the average optical density for all duplicate wells and then interpolated on
a standard curve utilizing a 4-parameter non-linear regression curve fit.
Several precautions were taken to increase the accuracy and reliability of the cortisol
sample readings. Individuals processing the samples were kept blind to the study design and
study hypothesis. To obtain a robust measure of the cortisol concentration, each sample was
processed in duplicate and the mean cortisol concentration of the two samples was used as the
final outcome. Finally, the samples were run on a plates composed of 90 wells. The samples
were distributed equally among the plates with respect to group.
Other. Participants were asked their height and weight and their self-reported parameters
were used to determine their Body Mass Index (BMI). Participants were also asked weather they
currently smoked or not. If participants reported that they did smoke, they were asked
standardized questions to quantify their daily tobacco use. Age of illness onset was obtained
from SCID interview and subtracted from current age to obtain the variable of illness duration.
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Procedures
Recruitment and Informed Consent. Participants were recruited through advertising,
including flyers posted in the community and Internet advertising. The majority of the clinical
sample was recruited through a local community outpatient clinic.
The UNLV Institutional Review Board (IRB) approved all of the research procedures.
Interested participants were provided with a brief study description, informed about the
associated risks and benefits, and were given an opportunity to ask questions. Those who stated
they would like to participate were asked to provide verbal consent to undergo a phone screening
and were asked a number of questions to establish study eligibility. Those who appeared to meet
the study criteria were scheduled to present for an in-person study at the laboratory. On campus
parking passes were provided for research participants. For those who are unable to secure
transportation, Taxi services were arranged and paid for. Participants were compensated at a rate
of $5.00 for every 30 minutes of study participation paid upon completion and were provided
with a lunch of their choice. Whenever possible, all study procedures were completed within the
same testing session.
Written informed consent was obtained from study participants prior to engaging in any
of the study procedures. After consent was obtained, participants completed the diagnostic and
screening procedures. Demographic information was obtained and participants completed the
SCID-5 interview to assess for DSM-IV classified Axis I psychiatric disorders. Psychiatric
interview was used to assess current symptomology. If participants were found to be eligible, the
remainder of the battery was completed. Trained doctoral level graduate students in conducted
the testing in quiet, private rooms. Breaks were provided when asked for by participants.
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Collection of Stress Response Measures. In order to evaluate stress response to the
TSST, saliva, heart rate, the VAS and PASA were administered at specified time points
throughout the evaluation. These time points were selected to allow for baseline estimates of
stress, stress response to the TSST, and resolution of stress following the TSST. Time points are
indicated in Table 1.

Table 1
Time Points for Collection of Stress Response Measures
Time Point

Stress Response Measure
Saliva

VAS

Heart Rate

1. Clinical Interview

X

X

X

2. Cognitive Testing

X

X

X

3. Relaxation

X

X

X

4. Anticipation

X

X

X

5. Immediately after TSST

X

X

X

6. 15 minutes after the TSST

X

X

X

7. 30 minutes after the TSST

X

X

X

8. 45 minutes after the TSST

X

X

X

9. Social Cognitive Testing

X

PASA

X

Note. VAS = emotion visual analogue scale; PASA = Primary Appraisal Secondary Appraisal
Scale.
As can be seen from Table 1, saliva was collected at 9 time points throughout the study.
The first saliva sample was collected one hour after participants arrived to complete the study;
participants were told that they were not allowed to eat, smoke, or drink liquids other than water
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one hour prior to sample collection and were therefore asked to collaborate with the assessors to
coordinate timing for when these samples could be collected (e.g., inform the administrator if
they would like a smoke break in to smoke immediately after the first sample is collected to time
an ensure that an hour passes before the second sample is collected). The second sample was
collected approximately one hour following the first one. This procedure ensured that
participants did not eat, smoke, or drink anything other than water one hour prior to sample
collection. Subsequent samples were timed to ensure that no samples were collected within an
hour of any of these activities. Collection of samples 3-8 occurred during the TSST. Finally,
sample 9 was taken 45-60 minutes after sample 8. The sample was collected for participants who
had measures to complete following the TSST; however, participants were not asked to stay to
submit this sample if they had completed all of the other study procedures. More detail regarding
these samples is provided later in the procedures section.
Heart rate and VAS were collected at 8 time points (see Table 1). The first two time
points corresponded to clinical interviews and time points 3-8 were during the TSST. Heart rate
was measured by the study administrators who used their index and middle fingers to locate
participants’ pulse on their inner wrist. Once the pulse was located the number of beats detected
in a 15 second time period was multiplied by 4 to calculate the beats per minute. At this point,
participants were asked to complete a VAS.
The PASA was administered at time point 4, or the anticipation stage of the TSST, to
measure the participants’ appraisal of the task and their personal resources to meet the challenge.
Trier Social Stress Test. The Trier Social Stress Test (TSST) is a laboratory social stress
test designed to invoke a brief stress response. For the current study, a modified version of the
TSST was utilized. As stated previously, a meta-analysis of 208 laboratory studies found that the
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tasks that were most effective at eliciting a physiological response were unpredictable and
included social-evaluative threat (Dickerson & Kemeny, 2004). Studies that included a cognitive
task in addition to the aforementioned components were found to have the most robust response;
so cognitive tasks were also used in the current protocol. The Trier Social Stress Test was
completed between the hours of 13:00 and 16:00 to take advantage of the naturally occurring dip
in cortisol levels in the afternoon (Smythe et al., 1997).
The start of the TSST is marked by a relaxation phase. The participants were instructed to
relax alone in the same room they were assessed and were provided with neutral reading
materials (e.g., magazines about cooking and travel) during this time to reduce boredom. After
ten minutes of relaxation, the third salivary sample was collected. Participants were asked to fill
out a visual analog scale (VAS) asking them to tic the level of each emotion they were
experiencing in the moment, including nervous, scared, calm, excited, and happy. Responses
were measured in centimeters ranging from “Not at All” on the left to “Extremely” on the right
and ranged from 0-15 cm. (see appendix for copy of the scale). Next, participants’ heart rate was
measured.
The second phase is the anticipatory anxiety phase. Participants were informed that they
will be explaining to a panel of experts why they are suitable candidates for a job they would
like. Participants were led into another room where they were shown two confederates sitting
behind a desk in a room with a video camera and microphone. Participants were provided with a
pad of paper and a writing instrument for notes and were given 10 minutes to compose their
speech; however, they were not told how much time they would have. After ten minutes
planning, the fourth saliva sample was collected. At this point the participants were asked to
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complete the PASA and the mood VAS, and their heart rate was measured. Participants were
asked to leave their notes in the room where the speech was composed.
The performance phase was next. Participants were led into a room where they were
asked to deliver a speech in front of two trained judges explaining why they are the best
candidates for a job they desired. If subjects were silent for 20 seconds one of the confederates
would prompt, “You still have some time left. Please continue.” This prompt was only to be used
twice for each participant. In the event that a participant needed another prompt, as indicated by
20 seconds of silence, the confederates would ask the following questions one at a time: “What
are you challenges you think you might encounter on this job?”; “What are some qualities that
would make you good at this job?”; “Tell us about a time you resolved a conflict you are proud
of.” After the public speaking portion, the participants were asked to perform mental
calculations. They were asked to start at 1,793 and count backwards by subtracting 13’s. One of
the confederates corrected participants if they made an error and instruct them to restart at 1,793.
Participants were to perform calculations for two minutes. After this phase, participants were
escorted back into the testing room.
The next phase is the resolution phase. Once they returned to the testing room,
participants submitted the fifth saliva sample, completed the VAS and had their heart rate
measured. Participants were then debriefed. Participants were informed that this task was
designed to be stressful and that they were not being evaluated or recorded. Participants were
asked the following questions: 1) How do you think you did?; 2) What went well?; 3) What was
difficult?; 4) Did you try anything to make it less difficult? Did it work?; 5) How would you
describe the raters?; 6) Do you have any thoughts about what the raters thought of you? Once the
interview was completed the confederates came into the testing room to inform the participants
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that they did well and thank them for their participation. Participants were then left alone to relax
and the sixth, seventh, and eighth salivary samples were collected 15, 30, and 45 minutes after
completing the social stressor, respectively. These sampled were used to determine the resolution
of the stress response. When these samples were collected, participants also completed the VAS
and their heart rate was measured. A ninth salivary sample was collected approximately one hour
after participants completed the TSST if there were additional study procedures that needed to be
completed. Participants were not kept specifically to collect this salivary sample if they did not
have any other reason to stay in the lab.
Analyses
Evaluating Hypothesis I:
Hypothesis I: Based on previous research, it is hypothesized that individuals with schizophrenia
will demonstrate a smaller increases in cortisol in response to the TSST relative to healthy
controls. No group differences in heart rate, and ratings of negative emotions during the TSST
are expected. Previous research indicates that a greater cortisol response to a psychosocial
stressor tends to correspond with more subjective stress. It is hypothesized this relationship
would be reversed in schizophrenia so that individuals with greater cortisol response will report
less anxiety.
Differences in cortisol levels were evaluated using repeated measures ANOVA with
group (control vs. schizophrenia) as the between factor and time as the within factor. A
significant group effect would confirm the hypothesis.
Area under the curve (AUC) was calculated to obtain single measures of cortisol release
using the formulas recommended by Pruessner and colleagues (2003). The use of AUC formulas
is recommended as a means of reducing the number of comparisons when data across multiple
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time points is examined. There are two formulas: AUC with respect to ground (AUCg) and AUC
with respect to overall increase (AUCi). The AUCg is a measure that is related to “total
hormonal output,” while AUCi is thought to be more representative of responsivity or sensitivity
of the hormonal system to produce changes over time. The formulas are presented below:

Where n is the number of samples, i is the initial sample, m is the measure (of cortisol in
this case), and t is time between samples (e.g., t2 is the time between sample 2 and sample 3).
For the current study, the AUCg will be calculated for time points 3-8 as response to TSST is of
primary interest. For AUCi, time point 3 will be used as the baseline time point, m1, as it
immediately follows a resting period prior the TSST and participants are expected to be related
during this time. Similar to AUCg, time points 3-8 will be used for current analyses. ANOVA
will be used to examine differences in cortisol production between the groups.
Additionally, repeated measures ANOVA was used to determine if the two groups differ
significantly in cortisol production with respect to each of the time points. Repeated measures
ANOVA was also used to examine differences in VAS ratings.
Pearson correlations were used to examine the relationship between overall cortisol
released during the TSST and Primary Appraisal and Secondary Appraisal Scales from the
PASA, total score on the Defeatist Attitude Beliefs Scale, total score of the Perceived Stress
Reactivity Scale, and total score from the Toronto Alexithymia Scale-20.
Evaluating Hypothesis II:
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Hypothesis II: Similarly, it is hypothesized that people with schizophrenia who have better social
cognition and perform better on a test of everyday functioning will have a greater cortisol
response to the psychosocial stressor, while healthy controls with better social cognition will
have a smaller cortisol response. Repeated measures ANOVAs were used to examine group
differences in performance on social cognitive measures and assessment of skills of everyday
functioning. Pearson correlations were used to examine the relationship between the social
cognition measures and AUC.
Evaluating Hypothesis III:
Hypothesis III: It is also hypothesized that the prevalence of childhood adversity would
be greater in the schizophrenia group than among the healthy controls. Lastly, it is hypothesized
that childhood sexual abuse will account for more of the variance in AUC than other forms of
abuse. Pearson correlations were used to examine group differences in associations of cortisol
and levels of childhood abuse endorsed.
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CHAPTER 4
RESULTS
Data Screening
Accuracy of data file. Initially, data was screened and evaluated to ensure accurate of
data entry. Data was scored and entered twice. An excel program was used to detect
discrepancies between the two entries to ensure accuracy of data entry. Additionally, range and
frequency statistics were examined to identify data that is outside of an acceptable range and
missing data. Data was also examined to make sure that assumptions of parametric tests were
met.
Outliers. Outliers were identified using box plots. Outliers were considered scores that
were outside 1.5 times the interquartile range. These scores were converted to the next highest
score in the distribution so that they would continue to maintain their extreme position in the
distribution, but have decreased influence on measures of central tendency and variability
(Tabachnick & Fidell, 2013). This procedure was utilized for one score on the Sexual Abuse and
Physical Abuse subscales of the Childhood Trauma Questionnaire. Additional outliers in the
cortisol data were identified using this methodology and will be discussed below.
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Missing Data. A healthy control was missing a Transportation subtest score of the
UPSA; this participant did not complete this subtest due to examiner error. This score was
replaced by the mean performance of the healthy control group on this scale. A total of five items
from the PASA were left blank by the participants (two items by the HC group and three by the
SZ group). These values were replaced by the average of the rest of the rest of the subscale from
which they were missing. Two of the participants from the SZ groups did not complete the
Hinting Task and Picture Arrangement due to scheduling conflicts and those scores were
replaced with group means. Additional information about missing data and outliers with respect
to cortisol is discussed below.
Preliminary Analysis
Demographic information for the participants is summarized in Table 2. The
schizophrenia (SZ) group completed significantly fewer mean years of education and had
significantly lower mean IQ estimates than the healthy control (HC) group. The differences
observed in IQ and education were expected based on research that has established cognitive
deficits to be a core feature of schizophrenia (Aylward, Walker, & Bettes, 1984), which
negatively impacts IQ and contributes to lower academic achievement among people with
schizophrenia (e.g., Green, 1996). Because these observations are believed to be reflective of the
underlying psychopathology associated with schizophrenia, covariance procedures were not used
to correct their influence because doing so would essentially control for the independent variable
of interest (i.e., diagnosis). Groups did not differ significantly on age or ethnicity.
No significant differences in body mass index (BMI) were found, which is notable for the
current study because higher BMI has been found to be associated with higher cortisol
production (Fraser et al., 1999). With respect to nicotine use, one participant reported daily
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electric-cigarette (e-cigarette) use, and estimated that he uses one cartridge per day. According to
a review published in the American Journal of American Medicine summarizing findings from
687 articles, there is great variability in the doses of nicotine absorbed from E-cigarette use
(Glasser et al., 2016), therefore this participant is indicated separately in Table 2. Tobacco use
data for one HC participant was not available. Overall, no significant group differences were
found in smoking when examining categories of nicotine use. Nevertheless, it appears that the
SZ group uses more nicotine than the HC group. Analyses examining the relationship with
smoking and cortisol levels will be presented under hypothesis 1.
Table 2
Demographic Information by Group

Variable
Age
Education
Estimated IQ
Body Mass Index
Age of Illness Onset
Illness Duration
Ethnicity (%)
Caucasian
African American
Hispanic/Latino
Biracial
Other
Smoking (cigarettes/day; %)
0
1-10
11-20
20+
E-Cigarettes

Control
Mean (SD)
37.1 (10.0)
14.5 (2.3)
110.0 (18.0)
27.9 (4.5)
---

Group
Schizophrenia
Mean (SD)
43.9 (10.3)
11.7 (2.3)
84.4 (4.3)
30.9 (5.3)
20.9 (3.6)
23.0 (11.0)

58.8
17.7
5.9
11.8
5.9

37.5
25.0
12.5
12.5
12.5

82.4
11.8
0.0
0.0
5.9

50.0
12.5
25.0
12.5
0.0
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F
3.66
12.59
14.03
3.11
---

p
.07
<.001
<.01
.09
---

X2
1.78

.78

8.61

.07

p

Table 3 summarizes measures reflecting symptomatic functioning. As anticipated, the SZ
group had significantly higher levels of psychopathology across all measures including the
BPRS, SAPS and SANS.
Table 3
Symptoms Ratings by Group
Group
Control
Schizophrenia
Variable
Mean (SD)
Mean (SD)
F
p
BPRS
20.7 (2.8)
37.2 (9.5)
47.35
<.001
SAPS Total
0.8 (2.2)
21.3 (13.7)
36.87
<.001
Hallucinations
0.0 (0.0)
1.8 (1.6)
20.75
<.001
Delusions
0.0 (0.0)
1.9 (1.6)
24.63
<.001
Bizarre Behavior
0.0 (0.0)
0.4 (0.7)
6.16
.02
Thought Disorder
0.1 (0.3)
1.5 (1.4)
15.37
<.001
Note. BPRS = Brief Psychiatric Rating Scale; SAPS = Scale for Assessment of Positive
Symptoms; SANS = Scale for assessment of Negative Symptoms
Fourteen (87.50%) of the people in the SZ group were diagnosed with schizophrenia and
two (12.50%) were diagnosed with schizoaffective disorder. Ten (62.50%) of the people in the
SZ group were prescribed atypical antipsychotic medication, three (18.75%) were prescribed a
typical antipsychotic medication, one (6.25%) was prescribed an anti-depressant, and two
(12.50%) reported that they were not taking medication.
The results of self-report measures are presented in Table 4. The SZ group endorsed
significantly higher levels of alexithymia, as evidenced by a higher overall score on the Toronto
Alexithymia Scale-20 (TAS-20) and the three contributing factor scores, including Difficulty
Identifying Feelings, Difficulty Describing Feelings, and Externally Oriented Thinking.
Significant group differences were also observed in the total score of the Perceived Stress
Reactivity Scale, with the SZ group reporting higher levels of stress reactivity. However, not all
subtests were significantly different; only Work Overload and Social Evaluation subscales
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yielded significant group differences with the SZ group reporting higher levels of subjective
reactivity in these areas of functioning. Finally, a significant group difference was found in
Defeatist Performance Beliefs in the expected direction with the schizophrenia group endorsing a
greater degree of defeatist beliefs.
Table 4
Self-Report Measures by Group
Group
Control
Schizophrenia
Measure
Mean (SD)
Mean (SD)
F
p
TAS-20 Total
38.4 (7.1)
55.0 (10.1)
30.36 <.001
Difficulty Identifying Feelings
9.7 (3.1)
18.0 (6.9)
20.45 <.001
Difficulty Describing Feelings
10.7 (3.2)
15.4 (3.8)
15.13
<.01
Externally Oriented Thinking
18.0 (3.4)
21.6 (4.5)
6.91
<.01
PSRS Total
11.3 (7.0)
19.3 (8.5)
8.80
<.01
Work Overload
1.3 (1.6)
3.9 (2.2)
14.76 <.001
Social Conflict
3.1 (2.1)
4.6 (2.3)
3.61
.07
Failure
2.8 (1.7)
3.6 (1.7)
1.51
.23
Social Evaluation
2.2 (1.7)
4.3 (2.6)
8.10
<.01
Prolonged Reactivity
1.9(1.6)
3.0 (1.9)
3.33
.08
Defeatist Performance Beliefs
39.9 (9.0)
62.3 (17.3)
22.08 <.001
Note. TAS-20 = Toronto Alexithymia Scale-20; PSRS = Perceived Stress Reactivity Scale
Evaluating Hypothesis 1
Whenever possible, the cortisol samples were processed in duplicate and the average
concentration was used in the analyses. For samples that did not contain enough saliva to run in
duplicate, the concentration of the single sample obtained and processed was used. Five samples
in total did not have enough saliva to run in duplicate: three from one subject in the SZ group
and two samples from two different participants in the HC group. The inter-assay coefficient
variable was calculated to be 10.62%, which is below the Salimetrix cut off of 15%. Therefore,
the single samples are considered sufficiently reliable and no corrective measures were taken.
Samples were collected at approximately the same time for both of the groups. For the SZ group
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the average time of collection was 3:51 p.m. (sd=41 minutes), while for the HC group, the
average time of collection was 3:21 p.m. (sd = 35 minutes). When each of the times was
converted to minutes past noon (e.g., 3:15 p.m = 195 minutes) a two-sample revealed that the
differences were non-significant (F=0.005, p=0.94). Therefore, it seems that time of collection is
comparable for the two groups.
Eight participants (6 HC and 2 SZ) were missing cortisol data for time point 9. This
occurred because sample 9 was only collected if participants were completing other evaluation
procedures. These missing values were replaced with the average of the group to which they
belonged. Cortisol data for five samples was also missing for 4 participants (one HC participant
was missing 2 samples) at different time points throughout the study for two people from the
healthy control group and 2 people from the schizophrenia group. These data were missing
because four of the samples did not contain enough saliva to run (2 samples from HC and 2
samples from SZ) and one sample (S1) was not collected because the HC participant took a sip
of a beverage other than water before the sample was to be collected. These data were also
replaced with group means for each respective time point.
Outliers in cortisol concentrations were identified with respect to each group. Therefore,
means and standard deviations were calculated for the SZ and HC groups separately. No outliers
were identified in the schizophrenia group. There were nine outliers in the HC group (five of
these were generated by the same participant for time points 1-5) and three outliers in the SZ
group in the data, as indicated by inspection of a boxplot for values greater than 1.5 times the
interquartile range. These scores were converted to the next highest score in the distribution so
that they would continue to maintain their extreme position in the distribution, but have
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decreased influence on measures of central tendency and variability (Tabachnick & Fidell,
2013).
Correction of the outliers improved the skewedness and kurtosis of the group of the data.
The primary analyses were run with the corrected data and no changes in the results were
observed; therefore, the analyses presented below are for the original data.
Results of the cortisol analyses are presented in Figure 2 and Table 5. To examine group
differences in cortisol production, a 2x9 mixed model analysis of variance (ANOVA) was used
in which group served as the between-subjects variable and cortisol samples across the nine time
points were the repeated measure. Mauchly’s test indicated that assumptions of sphericity were
violated, W = 0.00, χ2 (35) = 222.70, p < 0.001. Therefore, degrees of freedom were corrected
using Greenhouse-Geisser estimates to interpret main and interaction effects. Results of the
ANOVA indicated significant main effects for group, F (1, 31) = 14.84, p < .001, η2 = .324, and
for cortisol levels, F (2.66, 46.94) = 9.23, p < .0001, η2 = .229, as well as a significant group by
cortisol level interaction effect, F (2.66, 82.42) = 4.76, p = 0.005, η2 = .133. To examine
whether replacement of means for cortisol sample 9 affected the main and interaction effects,
comparable analyses were conducted for time points 1 – 8. The main and interaction effects
remained significant with a significant main effect for group, F (1, 31) = 13.63, p < .001, η2 =
.305, and for cortisol levels, F (2.49, 77.12) = 8.58, p < .0001, η2 = .217, as well as a significant
group by cortisol level interaction effect, F (2.49, 77.12) = 4.81, p = 0.01, η2 = .134. Figure 2
shows the group by cortisol level interaction effect. Post hoc analyses indicated that the
interaction effect was accounted for primarily by the group differences in cortisol time points 5 –
9, where the HC group evidence a relatively larger increase in cortisol levels from time points 5
– 6, and a steeper rate of cortisol decline from time points 6 – 9 compared to the SZ group.
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Figure 2
Cortisol Concentrations by Time Point for Schizophrenia (SZ) and Healthy Controls (HC)
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Note.
HC = Healthy Control; SZ = Schizophrenia; B1 = Baseline 1; B2 = Baseline 2; TB = TSST
Baseline; TA = TSST Anticipation; PT = Post TSST; PT15 = 15 minutes Post TSST; PT30 = 30
minutes Post TSST; PT45 = 45 minutes Post TSST; F = Final.
The salivary free cortisol response with respect to ground (AUCg) and with respect to
increase (AUCi) were also calculated for the TSST (time points 3-8) to examine the time points
collected during the afternoon and those collected during the TSST. As stated previously, time
point 3, collected at the end of the relaxation phase, was used as the “ground” time point for
AUCg. Analyses revealed significant differences between the two groups for both AUCi F(1,31)
= 14.15, p < .005, η2 = .313, and AUCg F(1,31) = 7.55, p <.05, η2 = .196. This indicates that the
HC group produced significantly more cortisol both when baseline level of cortisol is accounted
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for and when it is not. The SZ group had lower baseline levels of cortisol and responded with
less cortisol at the times cortisol was sampled.
Pearson correlations were used to further examine relationships between cortisol
production and demographic factors, including smoking and duration of illness. The correlation
between number of cigarettes smoked per day and AUCI for the overall sample was r =-.25
(p=.17) and the correlation between number of cigarettes smoked per day and AUCg was r =-.13
(p=.48), both of these relationships fall in the small effect size range (Cohen, 1992). Illness
duration was calculated as age at assessment minus age of onset of psychiatric illness. For three
participants the age of illness onset was unavailable; therefore, illness duration could not be
calculated for them. To examine the relationship between illness duration is related to AUCg
Pearson correlation was used. The correlation between cortisol AUCg and illness duration was
calculated to be non-significant (r =-.06, p=.85).
To further examine the relationship between nicotine use, group, and cortisol production,
a 2 X 2 X 8 repeated measures ANOVA was used in which group (SZ vs. HC) and smoking
status (current smoker vs. non-smoker) served as between subjects variables, and time point
served as within subjects variables. Mauchly's test of sphericity indicated that the assumption of
sphericity had been violated, W = 0.01, χ2(27) = 166.16, p < .001, therefore Greenhouse-Geisser
correction was applied to correct the degrees of freedom. The results of the analysis indicated
significant main effect for time point, F(2.55, 71.51) = 7.80, p < .001, η2 = .218 and a significant
interaction effect between time point and group, F(2.55, 71.51) = 4.51, p =.01, η2 = .139. The
two-way interaction of time point by smoking status was not significant F(2.55, 71.51) = 0.63, p
=.57, η2 = .022. Additionally, the three-way interaction between time point, group, and smoking
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status was also non-significant [F(2.55, 71.51) = 0.16, p =.90, η2 = .006]. Overall, these findings
suggest that smoking status does not impact cortisol production in a detectable manner.
Table 5
Cortisol Concentrations by Time Point for Each Group
Time
Point

Corresponding
Event

1
Clinical Interview
2
Cognitive Testing
3
Relaxation
4
Anticipation
5
Post TSST
6
TSST + 15 mins.
7
TSST + 30 mins.
8
TSST + 45 mins.
9
Cognitive Testing
Note. TSST = Trier Social Stress Test.

Group
Control
Mean (SD)
7.6 (5.6)
10.5 (8.6)
6.6 (3.7)
6.1 (3.6)
8.3 (7.2)
16.2 (12.5)
13.3 (9.6)
9.4 (5.8)
5.4 (1.9)

Schizophrenia
Mean (SD)
4.3 (2.1)
5.5 (3.0)
3.5 (1.5)
3.7 (1.6)
3.4 (1.3)
5.0 (2.9)
4.4 (1.8)
3.9 (1.3)
3.0 (1.1)

F
5.07
4.72
10.43
6.40
7.02
12.03
13.11
13.69
19.49

p
<.05
<.05
<.01
<.05
<.05
<.01
<.01
<.01
<.01

Results of the heart rate analyses are presented in Figure 3 and Table 6. A 2 x 8 mixed
model ANOVA was used to examine heart rate across the time points. Group served as the
between subjects variable and heart rate time point was the repeated measure. Mauchly’s test
indicated that assumptions of sphericity were violated, W = .19, χ2 (27) = 47.99, p < .01.
Therefore, degrees of freedom were corrected using Greenhouse-Geisser estimates to interpret
main and interaction effects. The main effect for heart rate was significant, F (4.85, 150.30) =
16.74, p < .001, η2 = .351, although the main effect for group was not significant, F (1,31) =
3.37, p = .08, η2 = .098, nor was the interaction effect, F (4.85, 150.30) = .50, p = .77, η2 = .016.
Post hoc analyses revealed significant differences between groups on time points 2 and 3 (see
Table 6). There were also significant differences in heart rate between time points 1 and 5,
F(1,31) = 54.50, p < .001, η2 = .637 and time points 5 and 8, F(1,31) = 38.08, p < .001, η2 = .551,
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indicating significant increase in heart rate in response to the TSST and significant decrease in
heart rate following the TSST.
Table 6
Heart Rate by Time Point for Schizophrenia and Control Groups
Group
Time
Control
Schizophrenia
Point Corresponding Event
Mean (SD)
Mean (SD)
1
Clinical Interviews
62.8 (11.2)
70.0 (14.1)
2
Cognitive Testing
61.9 (10.8)
71.8 (13.4)
3
Pre-TSST Relaxation
67.5 (10.0)
75.3 (11.6)
4
Anticipation Stage
72.9 (11.2)
79.3 (13.7)
5
Post TSST
74.8 (12.9)
81.0 (15.4)
6
TSST + 15 mins.
68.9 (9.8)
75.5 (12.3)
7
TSST + 30 mins.
67.5 (8.9)
72.9 (11.8)
8
TSST + 45 min
66.1 (10.9)
72.0 (13.3)
Note. TP = Time Point; TSST = Trier Social Stress Test
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F
2.64
5.45
4.21
1.57
1.57
2.90
2.18
1.94

p
.11
.03
.05
.22
.22
.10
.15
.17

Figure 3. Heart Rate by Time Point for Schizophrenia (SZ) and Healthy Controls (HC)
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Note. HC = Healthy Control; SZ = Schizophrenia; B1 = Baseline 1; B2 = Baseline 2; TB = TSST
Baseline; TA = TSST Anticipation; PT = Post TSST; PT15 = 15 minutes Post TSST; PT30 = 30
minutes Post TSST; PT45 = 45 minutes Post TSST.
The Visual Analog Scales (VAS) were examined next. Because several of the study
participants expressed confusion about how the variable “Calm” was to be interpreted and some
people even reported that they coded it incorrectly for the majority of the study, calm was
excluded from the analyses. One participant in the SZ group was missing two emotions for time
point 8 (nervous and excited). Because there was no manipulation between time point 7 and 8,
time point 7 was carried forward to fill in the missing scores for time point 8.
To examine VAS results, a 2 X 4 X 8 mixed model ANOVA was used in which group
served as a between subjects variable, and emotion (Nervous, Scared, Excited, Happy) and time
point served as within subjects variables. Mauchly's test of sphericity indicated that the
assumption of sphericity had been violated, W = 0.00, χ2(230) = 614.56, p < .001, so
Greenhouse-Geisser correction was applied to correct the degrees of freedom. The results of the
analysis indicated significant main effects for VAS emotion, F(1.48, 45.74) = 68.05, p < .001, η2
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= .687, and for VAS time point, F(4.66, 144.30) = 6.27, p < .001, η2 = .168, although the main
effect for group was not significant, F(1,31) = 1.88, p = .18, η2 = .057. There was a significant
two way interaction effect for VAS time point by VAS emotion, F(8.84, 274.04) = 4.68, p <
.001, η2 = .131, although the two way interaction effects were not significant for VAS time point
by group, F(4.66, 144.30) = 0.86 , p = .50, η2 = .027, or VAS emotion by group, F(1.48, 45.74)
= 0.57, p = .52, η2 = .018. Finally, the three-way group by VAS emotion by VAS time point
interaction effect was significant, F(8.84,274.04) = 3.20 , p < .001, η2 = .131. This three way
interaction effect is presented in Figures 4a-d.
As can be seen from the figures, the interaction effect is accounted for by group
differences in the intensity of VAS emotions reported during the study that vary by VAS time
point. Post-hoc analyses were conducted to further examine the three-way interaction effect.
Results of these analyses indicated that compared to controls, during the baseline phase as
indexed from time points 1 to 3, the schizophrenia group indicated significantly higher VAS
Nervous, F(1,31) = 9.50 , p < .005, η2 = .235, and VAS Scared, F(1,31) = 7.07 , p < .05, η2 =
.186, although no such differences were present for VAS Excited or Happy (p’s > .05). During
the TSST, as indexed by time points 4 and 5, no significant differences were present between the
groups on any of the VAS emotions (p’s > .05). In the resolution phase, the schizophrenia group
had higher VAS excitement compared to controls, F(1,31) = 5.37 , p < .05, η2 = .148, although
there were no other significant differences between groups for any of the other VAS emotions
(p’s > .05). Based on these findings, the SZ group indicated significantly higher overall negative
emotions during the baseline phase, the control group exhibited a greater increase in negative
emotions during the TSST phase, and the schizophrenia group demonstrated increased
excitement in the resolution phase.
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Figures 4a-d.
Ratings of Nervousness, Fear, Excitement, and Happiness by Time Point for Schizophrenia (SZ)
and Healthy Control (HC) Groups
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Note. HC = Healthy Control; SZ = Schizophrenia; B1 = Baseline 1; B2 = Baseline 2; TB = TSST
Baseline; TA = TSST Anticipation; PT = Post TSST; PT15 = 15 minutes Post TSST; PT30 = 30
minutes Post TSST; PT45 = 45 minutes Post TSST.

Evaluations were present for VAS negative emotions at times 4 and 5 corresponding with
the anticipations stages and completions of the TSST, while cortisol increases were present at
time points 6 and 7, 15 and 30 minutes after the TSST, respectively. The lag in the rise of

70

cortisol concentrations is expected as unbound levels of cortisol continue to increase 15-20
minutes after a stressor’s cessation (Kirschbaum & Hellhammer, 2000). In contrast, the increase
in VAS negative emotions corresponds with heart rate data, which also peak at time points 4 and
6. This finding is expected given that, like the VAS ratings, heart rate is a more temporally
proximate measure of stress response compared to cortisol.
Task appraisal differences were examined on the Primary Appraisal and Secondary
Appraisal (PASA) scale. A 2 x 4 mixed model ANOVA was used to examine differences
between groups on the four PASA primary scales. Group served as the between subjects variable
and PASA primary scale scores were the repeated measure. Mauchly’s test indicated that
assumptions of sphericity were violated, W = .336, χ2 (5) = 32.43, p < .001. Therefore, degrees of
freedom were corrected using Greenhouse-Geisser estimates to interpret main and interaction
effects. The main effect for PASA score was significant, F (1.79, 53.60) = 7.59, p < .005, η2 =
.197, although the main effect for group was not significant, F (1,31) = 0.03, p = .86, η2 = .001,
nor was the interaction effect, F (1.79, 53.60) = .08, p = .90, η2 = .003. Similarly, no significant
group differences were present for the secondary scales, which are summary scores for the
primary scale, or on the stress index (see Table 7). Results indicate that the groups’ primary and
secondary appraisals, or evaluation of threat and personal resources to cope with the threat were
similar as measured by the PASA. Results of analyses presented in Table 7.
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Table 7
Primary Appraisal Secondary Appraisal Scale Scores (PASA) by Group
Group
PASA
Primary Scales
Threat
Challenge
Self-Efficacy
Control Expectancy
Secondary Scales
Primary Appraisal
Secondary Appraisal
Stress Index

Control
Mean (SD)

Schizophrenia
Mean (SD)

F

p

12.7 (5.2)
16.1 (3.0)
16.9 (3.6)
16.7 (4.0)

13.1 (3.9)
16.4 (3.8)
16.4 (4.4)
17.1 (3.9)

.05
.05
.10
.07

.83
.83
.75
.80

28.8 (6.7)
33.6 (6.5)
-4.8 (10.3)

29.4 (6.5)
33.5 (7.4)
-4.1 (11.0)

.07
.001
.04

.79
.97
.85

Pearson correlations were used to examine relationships between the variables for each of
the groups. Results indicate that the only significant correlation for either of the groups is
between AUCg and DPB due to small sample size. Effect sizes indicated by the correlations
(Cohen, 1992) reveal medium effect sizes were present between the AUCg and the PASA
primary and secondary appraisal scale score, and between the AUCi and the PASA secondary
appraisal score. A large effect size was present between AUCg and the DPB scale score for the
SZ group only. This data is presented in Table 8.

72

Table 8
Correlations among Demographic Variables and Self-Report Measures with AUC Measures per
Group
Variable

Control
AUCi
AUCg

Schizophrenia
AUCi
AUCg

P.A.
S.A

-.04
.11

-.04
.09

.05
.23

-.25
-.35

TAS
PSRS
DPB

-.09
-.17
-.08

.05
-.16
-.08

.01
-.12
-.19

-.18
-.01
-.50*

Note. * p < .05; AUCi = Area Under the Curve overall increase; AUCg = Area Under the Curve
with respect to ground; P.A. = PASA’s Primary Appraisal scale; S.A. = PASA’s Secondary
Appraisal scale; DPB = Defeatist Performance Beliefs; PSRS = Perceived Stress Reactivity
Scale
Participants’ free response answers to the questions asked after the TSST were reviewed.
There were several differences between the responses of the HC and SZ groups. For example,
the HC group was more likely to evaluate their performance in neutral or favorable terms
(“pretty good”; “could be better”); while the SZ group was more likely to use negatively charged
terms like “terrible” to describe their performance. Additionally, the SZ group was more likely
to describe the raters in negative terms compared to the HC group. Interestingly, the SZ group
more often reported being perceived in a negative manner and more frequently reported feeling
judged by the raters for based on race, low education, or having a mental illness. The interested
reader is directed to the appendix to examine the raw responses.
Hypothesis 2
Results of the social cognitive measures and functional outcome measure are presented in
Table 9. To examine group differences in functioning, UPSA scores were examined in a 2x5
mixed model analysis of variance (ANOVA) which group served as the between-subjects
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variable and UPSA scaled scores were the measure. Mauchly’s test indicated that assumptions
of sphericity were violated W= 0.44, χ2 (9) = 23.89, p < 0.01. Therefore, degrees of freedom
were corrected using Greenhouse-Geisser estimates to interpret main and interaction effects.
Results of the ANOVA indicate that there was a significant main effect for group, F (1,31)
=10.95, p < .005, η2 = .261, and for UPSA subtest score, F (2.73,84.58) = 2.97, p < .05, η2 =
.087, although the interaction effect between the UPSA subscales and the group was not
significant, F (2.72,84.58) = 1.35, p = .26, η2 = .042. Post-hoc analyses revealed that group
differences were primarily driven by difference between Planning, Finance and Communication
subtests. See Figure 5 for plots of group means.
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Figure 5
UPSA Subtests Scores for Schizophrenia (SZ) and Healthy Controls (HC)
20
18
Mean Subtest Scores

16
14
12
10

HC

8

SZ

6
4
2
0
C/P

Fin

Comm

Transp

House

UPSA Subtests

Note. HC = Healthy Control; SZ = Schizophrenia; UPSA = UCSD Performance-Based Skills
Assessment; C/P = Comprehension/Planning; Fin = Finance; Comm = Communication; Transp =
Transportation; House = Household.
A 2x3 mixed model ANOVA was used to evaluate differences between the groups’
performances on social cognitive tests. In this analysis, group was the between subjects variable
and total scores from the Eyes Test, Hinting Test, and Picture Arrangement were the within
subjects variable. Assumptions of Mauchley’s test of sphericity were met, W = 0.90, χ2 (2) =
3.33, p = 0.19, therefore, no corrections were applied. Results indicated that the main effect for
social cognitive test was significant, F(2,62) = 194.54, p < .001, η2 = .863, as was the main effect
for group, F(1,31) = 21.83, p < .001, η2 = .413. The interaction between the tests of social
cognition and group was also significant F(2,62) = 3.44, p < .05, η2 = .100. See Table 9 for group
means.
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Given that scores from the social cognitive measures are not standardized which obscures
meaningful interpretation of the main effect for social cognitive test and the interaction effect,
standard scores (z) were computed for each social cognitive measure using the mean and
standard deviation of the control group for each test. These standard scores were used in the post
hoc analysis. The interaction effect is presented in Figure 6. Post hoc analysis comparing the
groups indicated the schizophrenia group performed significantly worse than controls on all
social cognitive measures, as reported in Table 9. Repeated measures ANOVA that included the
social cognition standard scores for the schizophrenia group indicated a significant overall effect,
F(2,30) = 3.67, p < .05, η2 = .196. Contrasts indicated significant differences between scores for
the Eyes Test and Picture Arrangement, F(1,15) = 5.19, p < .05, η2 = .257, but no significant
difference between Picture Arrangement and the Hinting Test, F(1,15) = 0.01, p = .97, η2 = .001.
Table 9
Measures of Social Cognition by Group
Measure

Group

Control
Schizophrenia
Mean (SD)
Mean (SD)
Eyes Test (Total)
28.1 (3.1)
20.8 (7.1)
Hinting Task (Total)
14.5 (3.0)
10.5 (3.3)
Picture Arrangement (SS)
10.8 (2.6)
7.6 (3.1)
UPSA Total
83.8 (8.5)
69.7 (16.7)
Activities/Planning
17.6 (1.8)
14.4 (4.9)
Finance
17.1 (1.7)
12.1 (5.1)
Communication
14.9 (1.9)
12.9 (2.8)
Transportation
17.3 (2. 8)
13.1 (6.1)
Household
17.4 (3.1)
14.1 (6.4)
Note. UPSA = UCSD Performance-Based Skills Assessment.
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F
14.70
12.82
10.54
3.61
6.57
15.48
5.64
6.28
3.61

p
<.005
<.005
<.005
<.005
<.05
<.001
<.05
<.05
.07

Figure 6
Interaction Effect for Social Cognitive Test Scores

1
0.5
0

Z-score

-0.5
-1
-1.5

HC

-2

SZ

-2.5
-3
-3.5
Eyes Test

PA

Hinting Task

Social Cognitive Test

Note. HC = Healthy Control; SZ = Schizophrenia; PA = Picture Arrangement.
Pearson correlations were used to examine the associations between these measures and
cortisol production for the schizophrenia and control groups. No significant correlations were
found when groups were examined individually due to small sample size. Effect sizes indicated
by the correlations (Cohen, 1992) indicate medium effect sizes were present between AUCg and
Hinting Task, and AUCi and Picture arrangement for the SZ group. In both instances the
relationship was negative suggesting that better performance on tests of social cognition is
inversely related to AUC. No correlations of this magnitude were found in the healthy control
group. Results of the correlation analyses are presented in Table 10.
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Table 10
Correlations among Social Cognitive Variables with AUC Measures per Group
Measure
Eyes Test
Hinting Task
Picture Arr.
UPSA

Control
AUCi
AUCg
.24
.13
-.02
.01
-.16
-.18
.23
.26

Schizophrenia
AUCi
AUCg
-.25
-.08
-.12
-.42
-.40
-.13
.21
.09

Note. Picture Arr. = Picture Arrangement scaled score; UPSA = UCSD Performance Based
Skills Assessment; Small correlations are italicized (.1-.29); Medium correlations are in bold (.3.49)
Evaluating Hypothesis 3
Exposure to traumatic events between the two groups was examined. Mixed model
ANOVA revealed that the interaction effect between group and the number of traumatic events
endorsed as witnessed or experienced endorsed on the LEC was not statistically significant,
F(1,31) = 0.15 , p = .71, η2 = .005, or the subscale scores. These findings are in line with other
research indicating that people with schizophrenia do not endorse a greater number of traumatic
life events overall.
Conversely, there was a statistically significant interaction effect between group and the
levels childhood trauma endorsed on the CTQ, F(1,31) = 31.36 , p < .001, η2 = .503. The
interaction effect is driven by greater levels of childhood trauma found in the schizophrenia
group. This difference was also present for all CTQ categories of childhood abuse and neglect
(see Table 11).

78

Table 11
Ratings of Trauma by Group
Group
Measure
CTQ Total
Emotional Abuse
Physical Abuse
Sexual Abuse
Emotional Neglect
Physical Neglect
LEC
Happened to me
Witnessed it
Learned about it

Control
Mean (SD)
7.5 (7.6)
1.4 (2.4)
1.5 (2.0)
0.5 (2.2)
2.9 (1.2)
1.2 (1.5)
10.4 (9.4)
3.4 (2.4)
3.0 (3.1)
4.0 (4.0)

Schizophrenia
Mean (SD)
32.3 (16.5)
7.9 (4.2)
5.9 (5.8)
2.5 (3.4)
10.0 (5.1)
6.9 (4.4)
9.4 (7.1)
4.9 (3.5)
1.5 (1.8)
3.0 (4.6)

F
31.36
30.65
8.82
4.03
20.31
25.44
0.15
2.13
2.88
0.44

p
<.001
<.001
<.01
<.05
<.001
<.001
.71
.15
.10
.51

Note. CTQ= Childhood Trauma Questionnaire; LEC = Life Events Checklist.
Hierarchical multiple regression was used to determine if the addition of childhood abuse
and neglect improved the prediction of AUCi over childhood sexual abuse (CSA) alone. AUCi
was selected for this analysis because it better adjusts for lower baseline levels of cortisol in the
SZ group and is a better measure of HPA axis responsivity. Sexual abuse was designated as the
first step based on previous research that indicates that presence of CSA predicts conversion to
psychosis and schizotypal personality disorder beyond other types of childhood abuse and
neglect (Bechdolf et al., 2010; Afifi et al., 2011; Thompson et al., 2014). Levels of childhood
trauma were entered into the regression, with sexual abuse added as the first step, followed by
abuse (physical and emotional) and neglect (physical and emotional).
See Table 12 for details on each regression model. As can be seen, none of the models
run reached statistical significance; therefore, associations between AUC and childhood abuse
were examined using correlations.
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Table 12
Results of Hierarchical Multiple Regression

Constant
Sex Abuse
Emot Abuse
Phys Abuse
Emot Neg
Phys Neg

Model 1
B
β
554.97
-47.00
-.27

AUCi
Model 2
B
640.44
-21.04
-12.55
-17.59

Model 3
β

-.12
-.10
.21

B
638.27
-10.70
-15.41
-16.38
-17.16
9.38

R2

.04

.04

-.01

F

2.47

1.45

0.92

∆ R2
∆F

.07
2.47

.06
.95

.01
.23

β
-.06
-.13
-.19
-.18
-.13

Notes. Sex Abuse = Sexual Abuse on CTQ; Emot Abuse = Emotional Abuse on CTQ; Phys
Abuse = Physical Abuse on CTQ; Emot Neg = Emotional Neglect on CTQ; Phys Neg = Physical
Neglect on CTQ.
Pearson Correlations were used to examine associations between childhood trauma and
AUCi and AUCg; results of this analysis can be found in Table 13. Small to medium
associations between sub-scales of the CTQ and area under the cure for the SZ and HC groups
were found. Interestingly, total CTQ scores were positively correlated with AUCi for the HC
group while a negative association was found for the SZ group.
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Table 13
Correlations Among CTQ and AUC per Group

Measure
CTQ Total
Emotional Abuse
Physical Abuse
Sexual Abuse
Emotional Neglect
Physical Neglect

Group
Control
Schizophrenia
AUCi AUCg
AUCi AUCg
.31
.15
-.17
.04
.33
.16
-.26
-.13
.01
.02
-.40
-.17
-.14
-.15
.03
.05
.36
.19
-.23
.33
.24
.18
.11
.29

Note. Small correlations are italicized (r= .1-.29); Medium correlations are in bold (r=.3-.49);
CTQ = Childhood Trauma Questionnaire.
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CHAPTER 5
DISCUSSION
The current study contributes to the growing field of work investigating abnormal
physiological response to psychosocial stress in schizophrenia. Present results are in line with
previous studies that have found an attenuated cortisol response to psychosocial stressors in
schizophrenia at various stages of illness including inpatient, clinically stable outpatient, first
episode, chronic, and those at clinically high risk for developing schizophrenia (Ciufolini,
Dazzan, Kempton, Pariante, & Mondelli, 2014; Pruessner et al., 2013; van Venrooij et al., 2012;
Jansen, Gispen-de Wied, & Kahn, 2000; Jansen et al., 1998). Results from the present study
confirm the finding of attenuated stress response in schizophrenia relative to the healthy controls,
both in overall cortisol production (AUCg) and with respect to baseline cortisol levels (AUCi)
during the TSST.
The groups were comparable on smoking behaviors and body mass index (BMI),
suggesting that these results are not better accounted for by other factors impacting physiological
functioning. The control group, recruited through Internet advertising, represented a group of
individuals who were likely to differ from the SZ group solely on the variable of interest, which
is the diagnosis itself. This procedure selected for individuals without a psychiatric diagnosis that
would ensure internal consistency of the experiment itself, as the results of this sample would
likely model relationships between variable of interest that exist in people who are similar on all
variables except for the presence of schizophrenia. This procedure accounts for discrepancies in
the exclusion rates between the two groups, as referring clinicians aware of exclusion criteria,
which eliminated a greater portion of inappropriate candidates. This may contribute to some
problems with interpretation, such as the gap in IQ between the two groups; however, to this
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author’s knowledge there have been no reported findings examining the relationship between
stress response to the TSST and IQ.
Similar to the findings reported by Pruessner and colleagues (2013), baseline cortisol
levels were lower for the clinical group than healthy controls. This finding is true for the
relaxation time point of the TSST and the two time points prior to the start of the TSST. Lower
cortisol production in SZ is contrary to finding from Walker & Diforno (1997) who reported that
levels or cortisol are higher among people with schizophrenia. It may be feasible that
discrepancies in baseline cortisol levels in current study may be due to differences in subjective
experiences that are not reflected by the VAS. Overall, this baseline difference is not well
understood.
Nevertheless, the present findings of diminished cortisol response in the SZ group are
consistent with the compelling accumulation of evidence suggesting that early trauma exposure
is associated with an increased risk for psychiatric disorders in adulthood. Patterns of cortisol
stress response have been observed to vary across disorders. For example, women with a positive
history of childhood abuse and current diagnoses of depression and PTSD have exhibited a
pattern of increase cortisol response to psychosocial stressors (Heim et al., 2002). Similarly,
differences in reactivity have been observed between patients with schizophrenia and depression
(Ciufolini et al., 2014) suggesting that the HPA axis may be uniquely involved in various forms
of psychopathology. Thus, further research accounting for factors such as lifetime trauma
exposure, gender, and other variable of interest is warranted.
Another potential explanatory mechanism could be an enhanced feedback resulting from
a down regulation of CRF receptors with an addition of increased negative glucocorticoid
feedback. Interestingly, differences found in current study parallel the diminished cortisol
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production in response to a psychosocial stressor in males with a history of adverse childhood
events reported by Elzinga and colleagues (2008).
Despite the group differences found in current work, the use of cortisol as a biomarker
has been discouraged due to multiplicity of factors that trigger HPA axis activation. For example,
Hellhammer and colleagues (2009) point out dissociations between salivary cortisol levels and
adrenocorticotropic hormone, corticotrophin releasing factor, arginine vasopressin (AVP), and
cortisol levels in blood and urine. The authors list several factors psychological and
physiological factors that impact associations (Kudielka, Hellhammer, & Wüst, 2009). While
the pattern of hypo-responsivity has been largely consistent in the group of studies examining the
TSST in schizophrenia, a solid case for clinical utility of a biomarker has yet to made as no
studies have examined the normalization of the cortisol stress response following treatment.
Additionally, there is little agreement about the etiology of this presentation, including teasing
apart weather the blunted response is a predisposing/vulnerability factor or a condition that is the
result of ineffective coping with trauma or other stressors. Overall, future research is warranted
to bolster the case for using the stress response as a biomarker.
Current work provides additional support for the increased negative feedback of
glucocorticoid receptors in response to chronic stress. The lack of variation in the cortisol
response observed in the SZ sample appears to be tied to hypo-cortisolism as reported by King &
Hegadoren, 2002. Further support can be observed among healthy individuals who live in
stressful conditions for long periods of time. However, in the present study the relationship
between duration of illness and cortisol production was not found to be significant; this may
potentially be due to lack of variability in the cortisol data or, as previously mentioned, the
multitude of factors that impact cortisol production.
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The present findings provide convergent evidence of impaired activation of the HPA axis
in response to social stressors. This may offer at least a partial explanation of the social cognitive
deficits reported for people with schizophrenia (Green et al., 2012; Fett et al., 2011) as it is
possible that abnormal reactivity is due to aberrant functioning in key brain regions, particularly
within the limbic system. Structural abnormalities in key limbic regions have been widely
reported in individuals with schizophrenia (e.g., Tamminga et a., 1992; Bogerts et al., 1990).
Elevations in cortisol production have been demonstrated to increase corticotropin-releasing
hormone (CRH) mRNA expression the amygdala, which resulted in exaggerations in the fear
response (Schulkin et al., 1998).
Results from the current study suggest that there may be associations between social
cognition and cortisol response for people with schizophrenia. It is possible that better social
cognitive abilities may leave one with a better sense of control in social situations. One potential
explanatory mechanism is that people with naturally higher social cognition tend to experience
interacting with others as more positive and are therefore less stressed in anticipation of social
encounters. Further research examining this relationship is warranted.
It is also interesting that cortisol levels at time point 2, sampled three hours after the
participants had been the in laboratory, was one of the highest cortisol levels for the SZ group.
Time point 2 occurred during the diagnostic and symptom assessments. This may suggest that
the clinical group found the diagnostic and symptom assessments and neuropsychological testing
more stressful than the healthy controls; however, this is not reflected in the VAS appraisals of
nervousness. Additionally, visual inspection indicates that time point 2 is higher for the SZ than
time point 1, which would argue against a failure to habituate to the laboratory environment.
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Finally, a similar cortisol increase was present for the controls, suggesting that the effect was not
specific to the schizophrenia group.
To this author’s knowledge, this is the first study to conduct a modified version of the
Trier Social Stress Testing using live confederates with people with schizophrenia. The
published studies using laboratory psychosocial stress tasks employ an imagined panel (e.g.,
leading the participant to believe that they are being evaluated by someone behind two-way
glass) or inform the subjects that they are being recorded. Some evidence exists in support of the
idea that a live panel produces a greater cortisol response relative to an imagined panel (Kelly et
al., 2007). The present task was effective at eliciting a physiological response as indicated by
greater levels of anxiety endorsed during the TSST relative to baseline measures and increased
heart rate in both groups. While the participants in the current study reported finding the task
stressful, no adverse effects were reported or observed, which may have positive implications for
future research considering employing this paradigm. Additionally, most studies have not
utilized a topic related to professional experience because it has been reasoned that patients may
have less experience with interviews and would therefore experience the TSST differently from
healthy controls (e.g., Brenner, et al., 2011). The current work suggests that despite potentially
less interviewing experience, the manipulation was successful and experienced in a similar
manner by the groups.
The current study did not find evidence to support the claim that the schizophrenia group
found the task less stressful than the healthy control group based on the visual analog scales
where similar levels of negative emotions were reported by both groups during the TSST. Nor
were differences found on participants’ appraisal of threat (primary appraisal) or their perception
of their ability to meet the perceived challenge (secondary appraisal) of the TSST. Similarly, the
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schizophrenia group exhibited comparable increases in heart rate to the healthy controls,
indicating that the schizophrenia group found the task stressful and that other facets of
physiological responding were intact. These findings may suggest that there is significant
overlap in the way that the groups perceived the TSST. Previous study of the PASA revealed a
positive correlation between magnitude of cortisol response and perceived threat of the TSST
among healthy college aged men (Gaab et al., 2005). For the current study, the correlation
between PASA and the AUCi and AUCg scores for the total sample were r= -.06 and r = -.07,
respectively, which is inconsistent with these prior findings due to lack of significance.
Interestingly, no group differences in task appraisal on the PASA were found in the current
study. Also, neither primary nor secondary appraisal was related to levels of cortisol. This
appears align with other groups that report similar evaluations of laboratory stressors by people
with schizophrenia and healthy controls. For example, van Venrooij et al. (2010) found that male
patients and healthy controls endorsed similar levels of nervousness and experience of control on
visual analog scales while preparing for a public speaking task. The similarities in tasks appraisal
are somewhat unexpected given that several studies have reported an increased prevalence of
negative emotion for those diagnosed with schizophrenia, people at ultra high risk for
schizophrenia, first-degree relatives of people with schizophrenia and people with schizotypal
disorder (Palmier-Claus et al., 2011; Phillips et al., 2011; Tessner et al., 2011; Myin-Germeys et
al., 2001).
To this writer’s knowledge, the only other study to use the PASA with people diagnosed
with schizophrenia found that the SZ group appraised a role-play as more threatening than
unaffected first degree relatives of people with schizophrenia and healthy controls (Delawalla,
2010); however, no group differences in threat were found for appraisal of a mathematic test of
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working memory. It is possible that the group difference was found due to healthy controls’
lower appraisal of the Role Play condition, as it appears that the schizophrenia group rated both
the calculation and role play conditions similarly. The similarities in reported subjective
experience could be due to other factors. For example, is possible that these differences are due
to a lack of more nuanced vocabulary as indicated by the difference in IQ observed between the
groups. It is also feasible that higher levels of Alexithymia in the SZ group may impair accurate
reporting of emotional state.
The free response portion of the study revealed that there were some differences in how
the two groups described their experience of the TSST. For example, those with schizophrenia
were more likely to use extreme language to describe the confederates (e.g., “evil” or “soulless”).
Overall, the schizophrenia group described their performance more negatively, and often cited
the difficulty of the subtraction component. People in the SZ group were also more likely to deny
trying anything to make the task easier, which may speak to the lower prevalence of adaptive
coping strategies among individuals with schizophrenia (Brenner, 2011). Conversely, people in
the control group were more likely to describe the task in neutral terms and identified specific
examples of things that they did well. Interestingly, some participants in the SZ group indicated
that they experienced the task as surreal (e.g., comparing it to the “twilight zone.”). This may
suggest that measures including stress-induced dissociation may be sensitive to finding
differences in the subjective experience of TSST. Finally, it is notable that those diagnosed with
schizophrenia were more likely to articulate concerns that they were disliked based on aspects of
their identity or achievement. For example, one participant stated that the confederates “hated”
him because of his race, another participant reported that he perceived that the confederates
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perceived him as uneducated or a “street person,” while another participant stated that the
confederates expected him to do badly because of his diagnosis.
The findings pertaining to the second two questions in the current work were somewhat
preliminary due to the relatively modest sample sizes, and should therefore be interpreted with
caution. Small to medium correlations were found between measures of social cognition and
cortisol response. Overall, the majority of the relationships for both the schizophrenia and
healthy control group were negative; indicating that poorer performance on social cognitive tasks
is associated with greater cortisol response. Interestingly, the relationships between a measure of
everyday skills and cortisol response were positive, suggesting the higher cortisol levels were
associated with better functioning. There is insufficient research to venture an interpretation of
these relationships presently; it is recommended that future studies examine these relationships to
determine if the findings are generalizable and address factors that might better elucidate
underlying mechanisms that account for these correlations.
The current regression analysis findings suggest that history of childhood abuse did not
account for the variance in overall cortisol response. The non-significant findings may be in part
accounted for by the relatively small sample size included in this study. Correlational analyses
did reveal a medium sized relationship between AUCi and total childhood trauma endorsed,
emotional abuse and neglect. This is somewhat unexpected, as childhood abuse has been found
to be associated with decreased stress response in healthy controls (Carpenter et al., 2007). For
the schizophrenia group, physical abuse was negatively associated with AUCi supporting the
prior findings regarding impact of abuse on cortisol. As expected, the current study found
greater prevalence of childhood trauma among people with schizophrenia. Trauma history has
been reported to contribute to the probability of developing adulthood psychosis apparently
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independent of genetics (Husted, Ahmed, Chow, Brzustowicz, & Bassett, 2010). Zubin and
Spring’s (1977) stress vulnerability model proposes that people have a biological vulnerability to
psychosis that provides a certain resilience to developing psychosis allowing some to tolerate
higher levels of stress without resulting in emergence of psychotic symptoms. Theoretically,
surpassing the threshold results in greater probability of developing psychosis. Therefore, the
experience of trauma leads to increased vulnerability of developing psychosis. Similarly, the
stress-sensitization model (Harkness, Hayden, & Lopez-Duran, 2015) posits that a person may
develop psychosis following a major stressor in the context of a biological vulnerability. After
the initial emergence of psychotic symptoms a person’s vulnerability theoretically increases and
the person may require less stress in the future to develop future problems. Therefore, the
experience of childhood trauma may result in increased biological vulnerability for psychosis to
stressors experienced later in life. Interestingly, in line with the stress sensitization model, the
clinical sample endorsed higher sensitivity to work overload and social evaluation on the PSRS.
Future studies may help expand generalizability of current work by including a broader
population of participants, including women. Studies including women may benefit from taking
into account hormonal factors (e.g., phase of menstrual cycle, use of oral contraceptives). The
addition of other control groups, such as first-degree relatives of people with schizophrenia may
help elucidate the role of genetics. Additionally, clinical control groups (e.g., people with
depression or anxiety disorders, or PTSD) may help evaluate the specificity of the attenuated
cortisol response.
One of the limitations in current study is the relatively modest sample size. Given that the
sample size in the current study may have limited ability to detect significant effects for some of
the analyses. Future studies may help expand generalizability of current work by recruiting a
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larger sample of participants. Future studies may help expand generalizability of current findings
by including women. Finally, variability in heart rate data precluded identification of heart rate
differences between the groups, even though there were apparent differences between the groups
that reflected changes observed in the cortisol data. More precise measurement of heart rate in
future studies might allow for significant differences to be observed by minimizing variance.
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APPENDIX A
Right now I feel:

Nervous

Not at
All

Extremely

Scared

Not at
All

Extremely

Calm
Not at
All

Extremely

Excited

Not at
All

Extremely

Happy

Not at
All

Extremely
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APPENDIX B
Trier Social Stress Test Appraisal Interview Responses
Table 14
HC Question 1: How Do You Think You Did?
Participant
01
02
03

Response
“Terrible;” “Unprepared”
“Could be better”
“Horrible. Hard to fill the time;” “Their eyes kept looking at me and they were very
serious;” “I felt I was doing something wrong”
04 “Different than expected;” “I thought they’d ask questions”
05 “Pretty well”
06 “Considering the little time to prepare - pretty good”
07 “Not enough time to prepare speech;” “I repeated things;” “I stopped a few times
because I thought time went faster;” “6.5/10”
08 “I’m not sure how to interview”
09 “Alright. Not a typical interview I’ve done because I typically cook during an
interview”
10 “Alright until I stopped then I needed to come up with more stuff.”
11 “Quite thrown without the notes. I finished my speech and they didn’t respond;” “Did
pretty badly because there wasn’t enough time to prepare and my thoughts didn’t
come out right”
12 “Mediocre. Covered good points but I was far too nervous;” “I had several awkward
pauses and didn’t make enough eye contact;” “I said ‘umm’ too much”
13 “The interview went well. I like talking to people”
14 “Covered most of the points but had trouble remembering them in order;” “Not as
fluid as I would like”
15 “Could have done better;” “I didn’t feel too muddled;” “I didn’t stutter but there
wasn’t much content”
16 “Pretty good.”
17 “It was fine, just the number part was difficult. I didn’t expect to go backwards. I’m
not good with numbers.”
Note. HC = Healthy Control.

93

Table 15
HC Question 2: What Went Well?
Participant Response
01 “When I was describing/presenting myself for the position; explaining why I was
qualified.”
02 “Started off well getting out what I prepared but I didn’t have time to prepare enough
to fill the time and improvising is more difficult.”
03 “Nothing. Especially not the math.”
04 “Filling the time;” “The was not my favorite;” “I made good eye contact with the
people.”
05 “Nothing.”
06 “I got my ideas out. Highlighted my experience and explained ability to contribute to
company.”
07 “Initial introduction went well. I got my goals set but didn’t elaborate much;”
“Organized at first but then came apart.”
08 “I made strong points”
09 “Everything was alright.”
10 “The fact that I recovered.”
11 “I stayed relaxed and didn’t show that I was flustered;” “I tried to cover my
nervousness.”
12 “D minus;” “Almost failed;” “The numbers threw off my concentration.”
13 “Had a decent game plan;” “When I was under time I felt like I kept my composure.”
14 “Getting thoughts across;” “I sold myself.”
15 “Counting backwards;” “I was surprised at my ability to stretch out the information in
my mind;” “Vamping”
16 “Continuing talking non-stop for five minutes’
17 “Nothing.”
Note. HC = Healthy Control.
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Table 16
HC Question 3: What Was Difficult?
Participant Response
01 “Very little time to prepare;” “I don’t have much experience interviewing;” “Speaking
was hard.”
02 “Improvising was difficult;” “Little time to plan what to say.”
03 “Counting.”
04 “The people were not responding;” “The math was hard;” “I made no eye contact.”
05 “I tried to get the interviewers to respond and it was hard when they didn’t;” “I come
off cold”
06 “Blank faces;” “No communication back and forth.”
07 “Coming up with a scenario. Thinking of something to say.”
08 “Gauging how long I should talk for;” “I didn’t get a response;” “Number part was
hard.”
09 “They seemed a little off putting because they didn’t respond”
10 “The counting was difficult;” “They didn’t respond.”
11 “No interaction so it was very one-sided,” “No follow up questions,” “I felt put on the
spot.”
12 “The math part was difficult;” “Being recorded”
13 “Talking about myself is difficult;” “Interviewers didn’t ask questions, interact and
stared.”
14 “Keeping my thoughts in order;” “Taking up five minutes.”
15 “Not having materials and not being prepared,” “I had little content and no aides.”
16 “Continuing talking non-stop for five minutes.”
17 “I didn’t expect to be asked to count backwards. It wasn’t difficult, just surprising.”
Note. HC = Healthy Control.
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Table 17
HC Question 4: Did You Try Anything to Make it Less Difficult? Did it Work?
Participant
01
02
03
04

Response
“I tried slowing down my breathing but I didn’t help;” “Open body language”
“I don’t know”
“Picturing the numbers”
“I told myself to ‘keep going,’ it can’t go on forever. This made the speech easier but
not the math.”
05 “I kept in mind that it’s not a real interview;” “This helped.”
06 “I told myself that as long as I share the best “me” everything will be OK.”
07 “I said ‘Umm’ a lot;” “It helped to look at something else in the room because it gave
me time to come up with something else to say.”
08 “Preparing the speech; this is a practiced pitch;” “I tried to look at them both equally.”
09 “I tried to figure out what they wanted but it didn’t work;” “Kept up eye contact.”
10 “I tried to keep it fun and light hearted.”
11 “Preparing. Having a rough plan helped.”
12 “No”
13 “Avoiding eye contact made me feel more confortable but I was aware that I should
have made more eye contact;” “I tried to slow myself down;” “Took deeper breaths.”
14 “I remembered my notes and it was helpful.”
15 “When I felt a stutter coming on I looked above them or looked at the floor to regain
composure.”
16 “I tried to remember things concisely and speak clearly. Yes, it worked.”
17 “Starting over again gave me a chance to get it again.”
Note. HC = Healthy Control.
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Table 18
HC Question 5: How Would You Describe the Raters? (If No Response: Likeable? Hostile?)
Participant
01
02
03

Response
“I think they’re OK;” “Likable”
“Stern;” “Not friendly.”
“Very serious;” “Intense;” “Pre-established feeling that they won’t hire me and I
couldn’t change their negative impression;” “It was hard to read them.”
04 “I assumed they’re professionals;” “They seemed very different from normal people;”
“They were abnormally neutral.”
05 “They kept an impassive attitude.”
06 “They were down-to-business, serious about the right candidate;” “Direct;” “They had
no emotion”
07 “Neural – almost robotic,” “Attractive.”
08 “They were unresponsive;” “The woman was slouching more and the guy maybe more
friendly;” “The woman seemed a little more skeptical.”
09 “They were impersonal;” “Felt awkward.”
10 “Stone cold;” “Seemed like they hated me.”
11 “They were cold;” “Nothing coming back.”
12 “They were stone faced – very good at not responding. They didn’t laugh.”
13 “Very distant and very neutral”
14 “They were not typical;” “There was no back-and-forth”; “It was difficult to read their
response.”
15 “Stoic;” “Firm;” “Business-like;” “Not likeable but not hostile;” “Their eye contact
was intense.”
16 “Stoic. Not likable.”
17 “They were nice. They were quiet. There’s not a lot to describe.”
Note. HC = Healthy Control.
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Table 19
HC Question 6: Do You Have Any Thoughts About What the Raters Thought of You?
Participant
01
02
03
04

Response
“Not a good candidate.”
“I couldn’t tell. They probably thought I was somewhat qualified.”
“No.”
“Maybe that I know how to give good speeches;” “Probably thought that I was
comfortable but don’t know how to subtract.”
05 “No – there was no body language until the end”.
06 “Not really.”
07 “Not really.”
08 “No.”
09 “Not really.”
10 “Not at all.”
11 “Hopefully fairly confident.”
12 “They thought I was stupid because of the math;” “Other parts went were pretty
good.”
13 “Geez. Very nervous. That’s it.”
14 “No. They didn’t ask questions. No feedback.”
15 “Average public speaker, but probably thought I was unprepared due to the huge gaps
of silence.”
16 “I didn’t think they cared. Irate maybe?”
17 “They saw that I didn’t have an answer and that I wasn’t getting it.”
Note. HC = Healthy Control.
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Table 20
HC Question 7: Do You Have Any Relevant Experience?
Participant
01
02
03
04
05
06
07
08
09
10
11

Response
“None.”
N/A
“Course instructor”
“Took speech and debate in high school.”
“Some experience studying and practicing public speaking.”
“Had to do a lot of pitches for work.”
“Not any interviews.”
N/A
N/A
N/A
“No interviews in 14 years, but do have casual “job chats.” Speak in front of people
on a daily basis for job.
12 “Spoke at many funerals.”
13 “Took speech class and taught for a bit in college;”
14 “I hired a lot of people.”
15 “Public speaking class in high school;” “I had to train people in at [work];” “I worked
[in customer service] and had to speak in front of ten to fifteen people.”
16 “Job interviews, training people.”
17 “I’ve had lots of job interviews and I try to be myself.”
Note. HC = Healthy Control; N/A = Not Available; [ ] = details were generalized to protect
confidentiality.
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Table 21
SZ Question 1: How Do You Think You Did?
Participant Response
01 “I don’t know;” “For most jobs I just give them a resume;” “I’m surprised they didn’t
have questions.”
02 “Terrible on the math;” “I don’t know how on the interview.”
03 “Not good. I didn’t know what to say;” “I said ‘umm’ a lot;” “I had trouble making
eye contact with the woman;” “Low confidence.”
04 “It was kind of scary;” “Felt like the twilight zone;” “I think I passed but didn’t do too
well;” “I felt shocked.”
05 “It was challenging. I don’t think I did too well.”
06 “Not very well. Seems like you’re in the twilight zone.”
07 “I think I did OK. It was frustrating because before the schizophrenia I was more
impressive.”
08 “I don’t know. Pretty good.”
09 “I kind of fell apart but I did a good job.”
10 “I ran out of speech time in 30 seconds. That was probably not good;” “Lots of pauses
and ‘umms.’”
11 “It was embarrassing. I think the next guy can do it but I can’t do it;” “He kept saying
start at 1022;” “They were silent.”
12 “I felt nervous; the questions made me nervous and counting backwards was hard. I
think I did poorly. I can’t count backwards, but the interview was OK.”
13 “Pretty good.”
14 “It didn’t come out how I wanted it to. I didn’t show the confidence that I wanted to.”
15 “Terrible. I had nothing to say.”
16 “OK. I wanted to get a job inventing things. I did OK with my speech.”
Note. SZ = Schizophrenia.
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Table 22
SZ Question 2: What Went Well?
Participant
01
02
03
04
05

Response
“I didn’t like the math part, but the interview was OK.”
“Nothing.”
“Nothing really. I felt intimidated;” “I felt put on the spot like a victim.”
“The voices went away;” “I didn’t feel scared but kind of weird.”
“They listened to me talk about my job and why I was qualified;” “I got a lot of
information out.”
06 “I wasn’t upset or nervous.”
07 “I picked a good topic;” “No problems filling the time;”
08 “I knew the subject and knew what to say.”
09 “It ended.”
10 “Nothing, really.”
11 “My speech went alright. I expressed myself and the way I feel;” “I was comfortable –
it was a nice room. I thought the camera was on and didn’t mind.”
12 “I don’t know. Probably the questions;” “Maybe I did well. Spoke pretty good.”
13 “Posture. What I said.”
14 “My effort. Kept smiling through the whole thing. It was uncomfortable but I stuck it
out.”
15 “That it was short. I had a sense of humor.”
16 “I brought my point across pretty well.”
Note. SZ = Schizophrenia.
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Table 23
SZ Question 3: What Was Difficult?
Participant
01
02
03

Response
“They didn’t ask about my training or questions;” “Not much.”
“Counting.”
“Seeing the camera and mike;” “The serious look on their faces… I felt put on the
spot;” “I felt like a victim.”
04 “The math was hard. I couldn’t subtract the numbers;” “It was like the twilight zone.”
05 “They weren’t smiling.”
06 “They were stone-faced. Not smiling or reacting;” “I asked them questions and they
didn’t respond.”
07 “I had trouble with the math;” “I felt thrown off by task.”
08 “The number thing. I did really bad on that;” “I had extra time;”
09 “I went blank in there and it was hard to answer questions;” “They had blank faces.”
10 “I’ve gone through interviews and they’re always stressful;” “I ran out of material.”
11 “They were silent and not talking at all;” “It wasn’t quick, it took ten minutes because
what I said wasn’t enough.”
12 “Counting backwards.”
13 “I shake a lot. It was very hard for me not to show them fear. That’s the hardest part.
Also, counting backwards.”
14 “Got nervous and forgot what to say. Hard to speak in clear, coherent sentences.”
15 “I was thinking about if I would have consequences for this; they didn’t hide the way
they were looking at me.”
16 “Trying to make the speech longer.”
Note. SZ = Schizophrenia.
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Table 24
SZ Question 4: Did You Try Anything to Make it Less Difficult? Did it Work?
Participant
01
02
03
04
05
06
07

Response
“I relaxed and tried to breathe. It worked”; “I used humor to make it better.”
“No.”
“I didn’t look at their faces. It kind of helpful.”
“No.”
“No.”
“I kept talking and that was helpful.”
“Having schizophrenia you get a lot of road blocks. I felt paranoid and nervous;” “I hit
a wall. Felt like something was wrong.”
08 “I had notes and everything;” “Kept in mind that it’s not real.”
09 “Not let it get to me because it’s fake.”
10 “I came up with something to say.”
11 “I cooperated and did by best;” “I’m sure the adding was slow.”
12 “I tried to calm myself down by breathing in and out. It was helpful;”
13 “Deep breathing, relaxing, and clearing my mind worked.”
14 “Smiling helped. Familiar examples, asking interviewers questions to make it more
comfortable.”
15 “I tried not looking straight in their face, I tried looking around the room.”
16 “No.”
Note. SZ = Schizophrenia.
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Table 25
SZ Question 5: How Would You Describe the Raters? (If No Response: Likable? Hostile?)
Participant
01
02
03

Response
“They’re regular people who want answers.”
“They were professional;” “Nice.”
“They were mean;” “Serious;” “Cold;” “Hostile;” “Their eyes sent messages of fear.”
“They didn’t smile.”
04 “Evil.”
05 “I can’t say. Maybe sad;” “They listened to what I had to say.”
06 “Stone faced and robotic;” “They were morbid and had no souls.”
07 “They weren’t judging me;” “They were OK. They didn’t do much;” “I didn’t notice
them.”
08 “Usually interviewers respond more. I didn’t know how to adjust to them. Usually I
adjust to people;” “They were flat. I couldn’t read them;” “They were kind of mean;”
“Unfriendly.”
09 “They were serious,” “I thought about cursing them out;” “Nothing can be said to
satisfy them;” “Disciplinarians;” “Cold.”
10 “They wanted to shoot me;” “They had a mean look on their faces;” “Kind of angry.”
11 “They were quiet. Sort of like hosts themselves;” “They were just doing their job.”
12 “They’re nice. Seemed professional.”
13 “Good, likable. All interview people are not likable.”
14 “Cold and stern. Not interested.”
15 “Very serious, like robots.”
16 “They were OK.”
Note. SZ = Schizophrenia.
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Table 26
SZ Question 6: Do You Have Any Thoughts About What the Raters Thought of You?
Participant
01
02
03
04
05
06

Response
“They liked me.”
“They thought I can’t count.”
“Not really.”
“They hated me because I’m black.”
“No idea.”
“I wonder if they thought I was mentally ill and needed help;” “They were testing my
patience.”
07 “No.”
08 “No. As you get older you see all types of people.”
09 “No.”
10 “I don’t know.”
11 “I don’t have the slightest idea;” “They knew I wasn’t that educated and that I was
more of a ‘street person’ not a ‘school person’.”
12 “No. I don’t know;” “I kept getting those numbers wrong. Maybe they thought I did
good.”
13 “No.”
14 “I thought they were aware of immature impulse to leave… Reflecting on it now it
seems like they didn’t like me.”
15 “No, I don’t know.”
16 “They thought I was OK. It was an OK speech.”
Note. SZ = Schizophrenia.
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Table 27
SZ Question 7: Do you Have Any Relevant Experience?
Participant
01
02
03

Response
“I worked a lot of jobs and have done lots of interviews.”
N/A
“Never really been in an interview. I’ve had one group interview and one one-on-one
interview;” “I don’t have public speaking experience;” “I’m not good at knowing my
own strengths.”
04 “I do some public speaking in church;” “I took some classes on how to interview.”
05 “I’ve had some interviews and passed some interviews.”
06 “I’ve had lots of different jobs and had lots of interviews. I used to be on a debate
team.”
07 “In high school I [was in a club]. We practiced making speeches and played
impromptu games.”
08 “I have been through interviews before and know what owners are interested in;” “I
took some classes about job interviews.”
09 “I spoke at [meeting] podium and interviewed for peer groups.”
10 “I’m more hands on and not good at interviews;” “I’m horrible at public speaking and
failed in college so I took [language class] instead.”
11 “No.”
12 “I’ve had some job interviews but not in the last ten years;” “I don’t have public
speaking experience.”
13 “Interview at a fast food restaurant as a teenager.”
14 “Spoke in front of advisory board in [mental heath center]. Teaching English in
[foreign country].”
15 “Took a class in middle school or high school.”
16 “Job interviews, a little bit of public speaking ‘in the streets’ (e.g., at the bus station or
restaurants)”
Note. SZ = Schizophrenia; N/A = Not Available; [ ] = details were generalized to protect
confidentiality.
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